關於我們 健康資訊 中心位置 最新消息      EN EN
logo

殷偉賢

殷偉賢

殷偉賢

振興醫院醫療副院長

    • 振興醫院醫療副院長
    • 國立陽明大學醫學系部定教授
    • 歐洲心臟學院 院士 (FESC)

掛號由此進
科別
  1. 心臟醫學中心
  2. 心臟血管內科
學歷
  1. 國立陽明大學臨床醫學博士
  2. 國防醫學院醫學系79期畢業
經歷
  1. 振興醫院心臟醫學中心心臟血管內科主任
  2. 振興醫院心臟內科主治醫師
  3. 桃園榮民總醫院內科主治醫師
  4. 台北榮民總醫院內科部特約醫師
  5. 台北榮總心臟內科主治醫師
  6. 台北榮總內科住院醫師、總醫師
專長
  1. 複雜心導管治療手術，包括冠狀脈氣球導管擴張術(PTCA)、血管支架裝置 術(stenting)、冠狀動脈旋磨術(Rotablation)、左主幹及血管完全閉塞(Chromic total occlusion)治療等。
  2. 複雜結構性心臟病(Structural heart disease)治療，包括經導管主動脈瓣膜植入術 (TAVI)、經導管先天及後天性心臟病治療等。
  3. 心臟節律器(Pacemaker)之裝置及追蹤。
  4. 胸前及食道心臟超音波心電圖檢查(Transthoracic and Transesophageal Echocardiography)
  5. 心臟循環學(Cardiology)及急診及重症加護醫學(Emergency and Intenisve Care)
認證
  1. 中華民國內科專科醫師
  2. 中華民國心臟專科醫師及指導醫師
  3. 中華民國心臟介入專科醫師
  4. 中華民國重症專科醫師
  5. 中華民國重症專科指導醫師
  6. 中華民國高級救命術指導員

發表

REFERRED PAPER:（*為通訊作者）

  1. Yin WH, Pao YL, Chen CH, et al. The value of computer-assisted analysis of the exercise electrocardiogram in the diagnosis of coronary artery disease. Acta Cardiol Sin 1991;7(2):88-94. (SCI)
  2. Tsang WP, Chen CH, Yin WH, et al. Value of transesophageal echocardiography in diagnosis of flail tricuspid valve. Acta Cardiol Sin 1991;7:114-7. (SCI)
  3. Chen CH, Lin SL, Hsu TL, Liou JY, Yin WH, et al. Long term follow-up after percutaneous balloon mitral valvuloplasty: an echocardiographic study. Acta Cardiol Sin 1991;7:150-6. (SCI)
  4. Chen CH, Lin SL, Yin WH, et al. Transesophageal color doppler flow mapping of iatrogenic left-to-right interatrial shunting after percutaneous transluminal mitral valvotomy. Echocardiography 1991;8(6):649-56. (SCI)
  5. Fang CH, Chen CH, Liou JY, Yin WH, et al. Effect of mitral regurgitation on pulmonary venous velocities: a transesophageal echocardiographic study. Acta Cardiol Sin 1992;8:169-75. (SCI)
  6. Chen CH, Lee WL, Liou JY, Yin WH, et al. Transthoracic versus transesophageal echocardiography to delineate multiple valve prolapse in patients with classic mitral valve prolapse. Acta Cardiol Sin 1993;9:149-54. (SCI)
  7. Chong NS, Yin WH, Chan P, et al. Evaluation of absorbed radiation dose to working staff during cardiac catheterization procedures. Chin Med J (Taipei) 2000;63:816-821.
  8. Chung N, Cho SY, Choi DH, Zhu JR, Lee K, Lee PY, Lee SH, Lee S, Wang JJ, Yin WH, et al. STATT: a titrate-to-goal study of simvastatin in Asian patients with coronary heart disease. Simvastatin Treats Asians to Target. Clin Ther 2001 Jun;23(6):858-70. (SCI)
  9. Lu TH, Chang HY, Hwu CM, Chiu HC, Yin WH, Pan WH. Comparison of official coders versus physician panel in assignment of underlying cause of death. J Formos Med Assoc 2001;100:365-9. (SCI)
  10. Yin WH, Jen HL, Chiang MC, et al. Preoperative selection of the best fitting electrode length in single-lead VDD pacing by transthoracic echocardiography. Acta Cardiol Sin 2001;17:201-208. (SCI)
  11. Yin WH, Jen HL, Chiang MC, et al. Development of an echocardiographic method for choosing the best fitting single-pass VDD lead. PACE 2002;25:761-767. (SCI)
  12. Chen JW, Yin WH, Chan WL, et al. Impairment of coronary microvascular function in patients with neurally mediated syncope. PACE 2003;26:605-12. (SCI)
  13. Yin WH, Chen JW, Jen HL, et al. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Eur J Heart Fail 2003;5:507-16. (SCI)
  14. Wang JJ, Yin WH, Huang CM, Jen HL, Young MS, Wei J. Predictors of cardiogenic shock complicating acute myocardial infarction and effects of early revascularization on mortality. Acta Cardiol Sin 2003;19:71-80. (SCI)
  15. Jen HL, Chen JW, Yin WH, Ho SJ, Young MS, Hsu TL. Transesophageal echocardiographic determination of coronary flow reserve – a validation study. Acta Cardiol Sin 2003;19:101-8. (SCI)
  16. Huang WP, Yin WH, Jen HL, Chiang MC, Feng AN, Young MS. C-reactive protein levels in chronic congestive heart failure. Acta Cardiol Sin 2004;20:7-14. (SCI)
  17. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS, Lin SJ. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 2004;147:931-8. (SCI)
  18. Yin WH, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS. Circulating soluble tumor necrosis factor-αand cell adhesion molecules in patients with acute cardiogenic pulmonary edema. J Emerg Crit Care Med 2004;15:9-19.
  19. Chiang MC, Yin WH*, Jen HL, Wang JJ, Huang WP, Feng AN, Young MS. Vascular cell adhesion molecule-1 as a prognostic marker in patients with end-stage heart failure. Acta Cardiol Sin 2004;20:94-104. (SCI)
  20. Morales D, Chung N, Zhu JR, Sangwatanaroj S, Yin WH, Lee K, Davies MJ, Shah A, Loeys T, Bilheimer D. Efficacy and safety of simvastatin in Asian and non-Asian coronary heart disease patients: a comparison of the GOALLS and STATT studies. Curr Med Res Opin 2004;20:1235-1243. (SCI)
  21. Lu TM, Ding YA, Leu HB, Yin WH, Sheu WH, Chu KM. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia. Am J Cardiol 2004;94:157-61. (SCI)
  22. Wei J, Chang CY, Chuang YC, Young MS, Huang CM, Yin WH, Tung DY, Lee WC, Lee SL, Chu CH. Heart transplantation at Cheng Hsin General Hospital in Taiwan: 15-year experience. Transplant Proc 2004;36:2374-6. (SCI)
  23. Lee KC, Chang CY, Chuang YC, Young MS, Huang CM, Yin WH, Tung DY, Lee WC, Lee SL, Sue SH, Wei J. Heart transplant coronary artery disease in Chinese recipients. Transplant Proc 2004;36:2380-3. (SCI)
  24. Kong CW, Tuan TC, Yin WH, Yu WC, Chen SA, Lin YJ, Huang CY, Chung SL. Development of Atrial Fibrillation in Patients with Atrioventricular Block after Atrioventricular Synchronized Pacing. PACE 2004;27:352-7. (SCI)
  25. Chiang MC, Yin WH*, Lin YT, Jen HL, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS. Brachial artery distensibility as a cardiovascular risk marker in asymptomatic individuals. J Intern Med Taiwan 2005;16:1-10.
  26. Fang L, Hsiung MC, Miller AP, Nanda NC, Yin WH, Young MS, Velayudhan DE. Assessment of aortic regurgitation by live three-dimensional transthoracic echocardiographic measurements of vena contracta area: usefulness and validation. Echocardiography 2005;22:775-781. (SCI)
  27. Yin WH, Chen JW, Tsai C, Chiang MC, Young MS, Lin SJ. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr 2005;24:988-997. (SCI)
  28. Feng AN, Yin WH*, Young MS, Lin MW. Association between 894G>T Polymorphism in the Endothelial Nitric Oxide Synthase Gene and Circadian Variation of Blood Pressure in Patients with Essential Hypertension. Acta Cardiol Sin 2005;21:137-45. (SCI)
  29. Patel V, Hsiung MC, Nanda NC, Miller AP, Fang L, Yelamanchili P, Mehmood F, Gupta M, Duncan K, Singh A, Rajdev S, Fan P, Naftel DC, McGiffin DC, Pacifico AD, Kirklin JK, Lin CC, Yin WH, Young MS, Chang CY, Wei J. Usefulness of live/real-time three-dimensional transthoracic echocardiography in the identification of individual segment/scallop prolapse of the mitral valve. Echocardiography 2006;23:513-8. (SCI)
  30. Hsiung MC, Wei J, Chang CY, Chuang YC, Lee KC, Sue SH, Chou YP, Hsiung R, Shih HC, Huang CM, Yin WH, Young MS, Tung TH. Long-term survival and prognostic implications after coronary artery bypass grafting in Chinese patients with coronary artery disease. Acta Cardiol 2006;61:519-24. (SCI)
  31. Yin WH, Jen HL, Chen JW, Lin SJ, Young MS. Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia. Diabetes Metab 2006;32:229-35. (SCI)
  32. Wang JJ, Huang WP, Yin WH, Young MS, Wei J. Application of cutting balloon angioplasty for undilatable venous stenoses causing dialysis access dysfunction. Acta Cardiol Sin 2006;22:91-95. (SCI)
  33. Yin WH, Chen JW, Young MS, Lin SJ. Increased Endothelial Monocyte Adhesiveness Is Related to Clinical Outcomes in Chronic Heart Failure. Int J Cardiol 2007;121:276-83. (SCI)
  34. Yi WH, Chen JW, Feng AN, Lin SJ, Young MS. Multimarker Approach to Risk Stratification Among Patients with Advanced Chronic Heart Failure. Clin Cardiol 2007;30:397-402. (SCI)
  35. Qi X, Cogar B, Hsiung MC, Nanda NC, Miller AP, Yelamanchili P, Baysan O, Wu YS, Law GY, Ko JS, Cheng CH, Lin CC, Huang CM, Yin WH, Young MS. Live/real time three-dimensional transthoracic echocardiographic assessment of left ventricular volumes, ejection fraction and mass compared with magnetic resonance imaging. Echocardiography 2007;24:166-73. (SCI)
  36. Jen HL, Yin WH, Chiang MC, Wang JJ, Huang WP, Feng AN, Yang YN, Lin CC, Tung TH, Young MS. The effects of starting statin therapy prior to percutaneous coronary intervention with drug-eluting stent on postprocedural myonecrosis and clinical outcome. Acta Cardiol Sin 2007;23:71-8. (SCI)
  37. Yin WH, Wang JJ, Jen HL, Chiang MC, Huang WP, Feng AN, Yang YN, Lin CC, Young MS. Low use of statins in patients with acute myocardial infarction: a single center experience. Acta Cardiol Sin 2007;23:79-88. (SCI)
  38. Lin YT, Yin WH*, Lin MW, Young MS. Brachial arterial stiffness index as a cardiovascular risk marker in asymptomatic individuals. Taiwan J Fam Med 2007;17:210-21.
  39. Wang JJ, Tung TH, Yin WH, Huang CM, Jen HL, Wei J, Young MS. Effects of moderate alcohol consumption on inflammatory biomarkers. Acta Cardiol 2008;63:65-72. (SCI)
  40. Manda J, Kesanolla SK, Hsuing MC, Nanda NC, Abo-Salem E, Dutta R, Laney CA, Wei J, Chang CY, Tsai SK, Hansalia S, Yin WH, Young MS. Comparison of real time two-dimensional with live/real time three-dimensional transesophageal echocardiography in the evaluation of mitral valve prolapse and chordae rupture. Echocardiography 2008;25:1131-7. (SCI)
  41. Pothineni KR, Wells BJ, Hsiung MC, Nanda NC, Yelamanchili P, Suwanjutah T, Prasad ANR, Hansalia S, Lin CC, Yin WH, Young MS. Live/real time three-dimensional Transthoracic echocardiographic assessment of pulmonary regurgitation. Echocardiography 2008;25:911-917. (SCI)
  42. Yin WH, Wang JJ, Chen HL, Jen HL, Chiang MC, Huang WP, Feng AN, Yang YN, Lin CC, Young MS. Statin therapy is Associated with improved clinical outcomes in patients undergoing emergency percutaneous coronary intervention. J Emerg Crit Care Med 2009;20:13-24.
  43. Yang HC, Liang YJ, Wu YL, Chung CM, Chiang KM, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Leu HB, Yin WH, Chiu T Y, Chen CI, Fann CSJ, Wu JY, Lin TN, Lin SJ, Chen YT, Chen JW, Pan WH. Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. PLoS one 2009;4:e5459. (SCI)
  44. Huang WP, Yin WH*, Chen JW, Jen HL, Young MS, Lin SJ. Fenofibrate attenuates endothelial monocyte adhesion in chronic heart failure: an in vitro study. Eur J Clin Invest 2009;39:775-783. (SCI) (NSC 95-2314-B-350-001)
  45. Singh P, Manda J, Hsiung MC, Mehta A, Kesanolla SK, Nanda NC, Tsai SK, Wei J, Yin WH. Live/real time three-dimensional transesophageal echocardiographic evaluation of mitral and aortic valve prosthetic paravalvular regurgitation. Echocardiography 2009;26:980-987. (SCI)
  46. Hernandez CM, Singh P, Hage FG, Nanda NC, Hsiung MC, Wei J, Chang CY, Lee KC, Sue SH, Yin WH. Live/real time three-dimensional transthoracic echocardiographic assessment of pericardial disease. Echocardiography 2009;26:1250-1263. (SCI)
  47. Hansalia S, Biswas M, Dutta R, Hage FG, Hsiung MC, Nanda NC, Singh P, Manda J, Kesanolla SK, Wei J, Yin WH. The value of live/real time three-dimensional transesophageal echocardiography in the assessment of valvular vegetations. Echocardiography 2009;26:1264-1273. (SCI)
  48. Hsiung MC, Tung TH, Chang CY, Chuang YC, Lee KC, Sue SH, Chou YP, Hsiung R, Huang CM, Lin CC, Yin WH, Young MS, Wei J. Long-term survival and prognostic implications of Chinese type 2 diabetic patients with coronary artery disease after coronary artery bypass grafting. HEALTH 2009;1:139-145.
  49. Hsuan CF, Huang CK, Lin JW, Lin LC, Lee TL, Tai CM, Yin WH, Tseng WK, Hsu KL, Wu CC. The effect of surgical weight reduction on left ventricular structure and function in severe obesity. Obesity 2010;18:1188-93. (SCI)
  50. Chen LH, Li CY, Shieh SM, Yin WH, Chiou AF. Predictors of fatigue in patients with heart failure. J Clin Nurs 2010;19:1588-1596. (SCI)
  51. Lin SH, Liu JH, Wei J, Yin WH, Chen HH, Chiu WT. A business model analysis of telecardiology service. Telemed J E-Health 2010;16:1067-73. (SCI)
  52. Jen HL, Yin WH*, Chen KC, Feng AN, Ma SP, Cheng CF, Young MS. Transradial Approach in Myocardial Infarction. Acta Cardiol 2011;66:239-45. (SCI)
  53. Chen KC, Yen DH, Chen CD, Young MS, Yin WH*. Effect of Emergency Department In-Hospital Tele-Electrocardiographic Triage and Interventional Cardiologist Activation of the Infarct Team on Door-to-Balloon Times in ST-Segment-Elevation Acute Myocardial Infarction. Am J Cardiol 2011;107:1430-5. (SCI)
  54. Yin WH, Chen YH, Wei J, Jen HL, Huang WP, Young MS, Chen DC, Liu PL. Associations between Endothelin-1 and Adiponectin in Chronic Heart Failure. Cardiology 2011;118:207-16. (SCI) (共同第一作者)
  55. Yang YN, Yin WH, Feng AN, Young MS, Chen JW, Lin SJ. Low-intensity Warfarin therapy for the prevention of stroke in patients with high-risk nonvalvular atrial fibrillation. Acta Cardiol Sin 2011;27:158-65. (SCI)
  56. Yin WH, Chen JW, Lin SJ, Young MS. Effect of irbesartan on angiotensin II-induced adiponectin expression in human cardiomyocytes. Acta Cardiol Sin 2011;27:244-51. (SCI)
  57. Joshi D, Bicer EI, Donmez C, Hsiung MC, Nanda NC, Sadat K, Sudhakar S, Ibrahim H, Pandey A, Karia N, Bhagatwala K, Yin WH, Wei J, Chang CY, Chung YC, Tsai SK, Dumaswala B, Dumaswala K. Incremental Value of Live/Real Time Three-Dimensional Transesophageal Echocardiography over the Two-Dimensional Technique in the Assessment of Aortic Aneurysm and Dissection. Echocardiography. 2012;29:620-30. (SCI)
  58. Tung HH, Chen SC, Yin WH, Cheng CH, Wang TJ, Wu SF. Self care behavior in patients with heart failure in Taiwan. Eur J Cardiovasc Nur 2012;11:175-82. (SCI)
  59. Yang HC, Liang YJ, Chen JW, Chiang KM, Chung CM, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Leu HB, Yin WH, Chiu TY, Chern CL, Lin SJ, Tomlinson B, Guo Y, Sham PC, Cherny SS, Lam TH, Thomas GN, Pan WH. Identification of IGF1, SLC4A4, WWOX, and SFMBT1 as hypertension susceptibility genes in Han Chinese with a genome-wide gene-based association study. PLoS One 2012;7:e32907. (SCI)
  60. Kuo TY, Kang MJ, Chen JW, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Leu HB, Yin WH, Chiu TY, Chen CI, Lin SJ, Pan WH. A Two-Stage Matched Case-Control Study on Multiple Hypertensive Candidate Genes in Han Chinese. Am J Hypertens 2012;25:804-11. (SCI)
  61. Chang HY, Lo LW, Lin YJ, Chang SL, Hu YF, Feng AN, Yin WH, Li CH, Chao TF, Hartono B, Chung FP, Cheng CC, Lin WS, Tsao HM, Chen SA. Long-Term Outcome of Catheter Ablation in Patients with Atrial Fibrillation Originating from the Superior Vena Cava. J Cardiovasc Electr 2012;23:955-61. (SCI)
  62. Wang CC, Chen JH, Yu WC, Cheng JJ, Yin WH, Wu CC, Li AH, Lin WS, Chen PS, Ueng KC, Huang JL, Tsai FC, Wang CH, Fu TC, Liu MH, Chen PR, Pai HY, Cherng WJ. 2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the Diagnosis and Treatment of Heart Failure. Acta Cardiol Sin 2012;28:161-195. (SCI)
  63. Yin WH, Wei J, Huang WP, Chen JW, Young MS, Lin SJ. Prognostic Value of Circulating Adipokine Levels and Expressions of Adipokines in the Myocardium of Patients With Chronic Heart Failure. Circ J 2012;76:2139-47. (SCI)
  64. Yin WH, Wu CC, Chen JW. Registry of Lipid Control and Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan — Rationality and Methods. Int J Gerontol 2012;4:241-6. (SCI)
  65. Tsai JR, Wang HM, Liu PL, Chen YH, Yang MC, Chou SH, Cheng YJ, Yin WH, Hwang JJ, Chong IW. High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients. Cell Oncol (Dordr) 2012;35:461-71. (SCI)
  66. Chang HY, Lin YJ, Lo LW, Chang SL, Hu YF, Li CH, Chao TF, Yin WH, Chen SA. Sinus node dysfunction in atrial fibrillation patients: the evidence of regional atrial substrate remodelling. Europace 2013;15:205-11. (SCI)
  67. Chang HY, Lo LW, Lin YJ, Chang SL, Hu YF, Li CH, Chao TF, Chung FP, Ha TL, Singhal R, Chong E, Yin WH, Tsao HM, Hsieh MH, Chen SA. Long-Term Outcome of Catheter Ablation in Patients with Atrial Fibrillation Originating from Nonpulmonary Vein Ectopy. J Cardiovasc Electr 2013;24:250-8. (SCI)
  68. Lee AP, Hsiung MC, Salgo IS, Fang F, Xie JM, Zhang YC, Lin QS, Looi JL, Wan S, Wong RH, Underwood MJ, Sun JP, Yin WH, Wei J, Tsai SK, Yu CM. Quantitative Analysis of Mitral Valve Morphology in Mitral Valve Prolapse Using Real-Time Three-Dimensional Echocardiography: Importance of Annular Saddle-Shape in Pathogenesis of Mitral Regurgitation. Circulation 2013;127:832-41. (SCI)
  69. Chang HY, Lo LW, Feng AN, Chiang MC, Yin WH, Young MS, Chang CY, Chuang YC, Hartono B, Chen SA, Wei J. Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients. Transplant Proc 2013;45:369-75. (SCI)
  70. Bhaya M, Mutluer FO, Mahan E, Mahan L, Hsiung MC, Yin WH, Wei J, Tsai SK, Zhao GY, Yin WH, Pradhan M, Beniwal R, Joshi D, Nabavizadeh F, Singh A, Nanda NC. Live/Real time three-dimensional transesophageal echocardiography in percutaneous closure of atrial septal defects. Echocardiography 2013;30:345-53. (SCI)
  71. Yin WH, Chen JW, Chen YH, Lin SJ. Fenofibrate modulates HO-1 and ameliorates endothelial expression of cell adhesion molecules in systolic heart failure. Acta Cardiol Sin 2013;29:251-60. (SCI) (NSC 95-2314-B-350-001)
  72. Chen YP, Chang KC, Tseng WK, Yin WH, Chen JW, Lee YT, Wu CC. Increased Rosuvastatin dose versus concomitant Fenofibrate and Rosuvastatin therapy to achieve lipid goal in patients with diabetes or atherosclerosis with metabolic syndrome. Acta Cardiol Sin 2013;29:421-28. (SCI)
  73. Chang HY, Yin WH, Lo LW, Lin YJ, Chang SL, Hu YF, Feng AN, Chiang MC, Young MS, Chang CY, Chuang YC, Chong E, Chen SA, Wei J. The utilization of twelve-lead electrocardiography for predicting sudden cardiac death after heart transplantation. Int J Cardiol 2013;168:2665-72. (SCI)
  74. Tsai JR, Chong IW, Chen YH, Hwang JJ, Yin WH, Chen HL, Chou SH, Chiu CC, Liu PL. Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells. Arch Pharm Res 2014;37:548-57. (SCI)
  75. Chung CM, Lin TH, Chen JW, Leu HB, Yin WH, Ho HY, Sheu SH, Tsai WC, Chen JH, Lin SJ, Pan WH. Common quantitative trait locus downstream of RETN gene identified by genome-wide association study is associated with risk of type 2 diabetes mellitus in Han Chinese: a Mendelian randomization effect. Diabetes Metab Res Rev 2014;30:232-40. (SCI)
  76. Jeng JS, Yin WH, Huang CC, Chuang SY, Yeh HI, Fang CC, Lin TH, Wang KY, Tseng WK, Huang LC, Ueng KC, Hsieh IC, Li YH, Pan WH, Wu CC, Chen JW; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan. J Formos Med Assoc 2015;114:1000-7. (SCI)
  77. Chiang KM, Yang HC, Liang YJ, Chen JW, Hwang SM, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Leu HB, Yin WH, Chiu TY, Chen CI, Lin SJ, Thomas GN, Tomlinson B, Guo Y, Gui HS, Sham PC, Lam TH, Pan WH. A Three-Stage Genome-Wide Association Study Combining Multilocus Test and Gene Expression Analysis for Young-Onset Hypertension in Taiwan Han Chinese. Am J Hypertens 2014;27:819-27. (SCI)
  78. Lin TH, Chuang SY, Chu CY, Lee WH, Hsu PC, Su HM, Li YH, Fang CC, Wang KY, Tseng WK, Li AH, Ueng KC, Hsieh IC, Huang LC, Wang CH, Pan WH, Yeh HI, Wu CC, Yin WH, Chen JW. The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan. Int J Med Sci 2014;11:381-8. (SCI)
  79. Tsai JR, Liu PL, Chen YH, Chou SH, Yang MC, Cheng YJ, Hwang JJ, Yin WH, Chong IW. Ginkgo biloba Extract Decreases Non-Small Cell Lung Cancer Cell Migration by Downregulating Metastasis-Associated Factor Heat-Shock Protein 27. PLoS One 2014;9:e91331. (SCI)
  80. Takeshita S, Asano H, Hata T, Hibi K, Ikari Y, Kan Y, Katsuki T, Kawasaki T, Masutani M, Matsumura T, Premchand RK, Rao SP, Suzuki T, Takahashi A, Takeda R, Tanaka S, Yamazaki S, Yin WH, Yoshimachi F, Saito S; NAUSICA Trial Investigators. Comparison of frequency of radial artery occlusion after 4Fr versus 6Fr transradial coronary intervention (from the Novel Angioplasty USIng Coronary Accessor Trial). Am J Cardiol 2014;113:1986-9. (SCI)
  81. Leu HB, Chung CM, Lin SJ, Lu TM, Yang HC, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Yin WH, Chiu TY, Chen CI, Pan WH, Chen JW. A novel SNP associated with nighttime pulse pressure in young-onset hypertension patients could be a genetic prognostic factor for cardiovascular events in a general cohort in Taiwan. PLoS One 2014;9:e97919. (SCI)
  82. Hsu CH, Ho WJ, Huang WC, Chiu YW, Hsu TS, Kuo PH, Hsu HH, Chang JK, Cheng CC, Lai CL, Liang KW, Lin SL, Sung SH, Tsai WC, Weng KP, Hsieh KS, Yin WH, Lin SJ, Wang KY. 2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension. Acta Cardiol Sin 2014;30:401-444. (SCI)
  83. Lin QS, Fang F, Yu CM, Zhang YC, Hsiung MC, Salgo IS, Looi JL, Wan S, Wong RH, Underwood MJ, Sun JP, Yin WH, Wei J, Jin CN, Tsai SK, Ji L, Lee AP. Dynamic assessment of the changing geometry of the mitral apparatus in 3D could stratify abnormalities in functional mitral regurgitation and potentially guide therapy. Int J Cardiol 2014;176:878-84. (SCI)
  84. Qu SH, Hsiung MC, Leng XP, Wei J, Du GQ, Houle H, Yin WH, Tian JW. Three-Dimensional Transesophageal Echocardiographic Study of Aortic-Mitral Valve Coupling after Coronary Artery Bypass Grafting. Echocardiography 2015;32:983-92. (SCI)
  85. Leu HB, Chung CM, Lin SJ, Chiang KM, Yang HC, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Yin WH, Chiu TY, Chen CI, Fann CS, Chen YT, Pan WH, Chen JW. Association of circadian genes with diurnal blood pressure changes and non-dipper essential hypertension: a genetic association with young-onset hypertension. Hypertens Res 2015;38:155-62. (SCI)
  86. Wei J, Yin WH, Lee YT, Hsiung MC, Tsai SK, Chuang YC, Ou CH, Chou YP. Intraoperative three-dimensional transesophageal echocardiography for assessing the defect geometries of mitral prosthetic paravalvular leak during transcatheter closure. J Chin Med Assoc 2015;78:158-63. (SCI)
  87. Ho LT, Yin WH, Chuang SY, Tseng WK, Wu YW, Hsieh IC, Lin TH, Li YH, Huang LC, Wang KY, Ueng KC, Fang CC, Pan WH, Yeh HI, Wu CC, Chen JW; Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (T-SPARCLE) Registry Investigators. Determinants for Achieving the LDL-C Target of Lipid Control for Secondary Prevention of Cardiovascular Events in Taiwan. PLoS One 2015;10:e0116513. (SCI)
  88. Looi JL, Lee AP, Fang F, Hsiung MC, Sun JP, Yin WH, Wei J, Tsai SK, Wan S, Wong RH, Underwood MJ, Lin QS, Jin CN, Chen L, Yu CM. Abnormal mitral-aortic intervalvular coupling in mitral valve diseases: a study using real-time three-dimensional transesophageal echocardiography. Clin Res Cardiol 2015;104:831-42. (SCI)
  89. Nakamura M, Wang YQ, Wang C, Oh D, Yin WH, Kimura T, Miyazaki K, Abe K, Mercuri M, Lee LH, Segers A, Buller H. Efficacy and Safety of Edoxaban for Treatment of Venous Thromboembolism: A Subanalysis of East Asian Patients in the Hokusai-VTE Trial. J Thromb Haemost 2015;13:1606-14. (SCI)
  90. Yin WH*, Tseng CK, Tsao TP, Jen HL, Huang WP, Huang CL, Wang JJ, Young MS. Transradial versus transfemoral rotablation for heavily calcified coronary lesions in contemporary drug-eluting stent era. J Geriatr Cardiol 2015;12:489-96. (SCI)
  91. Lu TH, Huang YT, Lee JC, Yang LT, Liang FW, Yin WH*, Kawachi I. Characteristics of Early and Late Adopting Hospitals Providing Percutaneous Coronary Intervention in Taiwan. J Am Heart Assoc 2015;4:e002840. (SCI)
  92. Yin WH*, Lu TH, Chen KC, Cheng CF, Lee JC, Liang FW, Huang YT, Yang LT. The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15 years in a Taiwanese population. Int J Cardiol 2016;209:103-113. (SCI)
  93. Yoon SH, Ahn JM, Hayashida K, Watanabe Y, Shirai S, Kao HL, Yin WH, Lee MK, Tay E, Araki M, Yamanaka F, Arai T, Lin MS, Park JB, Park DW, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Muramatsu T, Hanyu M, Kozuma K, Kim HS, Saito S, Park SJ; Asian TAVR Investigators. Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population. JACC Cardiovasc Interv 2016;9:926-33. (SCI)
  94. Wang KL, Chu PH, Lee CH, Pai PY, Lin PY, Shyu KG, Chang WT, Chiu KM, Huang CL, Lee CY, Lin YH, Wang CC, Yen HW, Yin WH, Yeh HI, Chiang CE, Lin SJ, Yeh SJ. Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Acta Cardiol Sin 2016;32:1-22. (SCI)
  95. Yin WH, Chen P, Yeh HI, Wang KY, Hung YJ, Tseng WK, Wen MS, Wu TC, Wu CC, Cheng SM, Chen JW. Combination with Low-dose Dextromethorphan Improves the Effect of Amlodipine Monotherapy in Clinical Hypertension: A First-in-human, Concept-proven, Prospective, Dose-escalation, Multicenter Study. Medicine 2016;95:e3234. (SCI)
  96. Du GQ, Hsiung MC, Wu Y, Qu SH, Wei J, Yin WH, Tian JW. Three-Dimensional Speckle-Tracking Echocardiographic Monitoring of Acute Rejection in Heart Transplant Recipients. J Ultrasound Med 2016;35:1167-76. (SCI)
  97. Chen KC, Yin WH*, Young MS, Wei J. In-hospital Tele-ECG Triage and Interventional Cardiologist Activation of the Infarct Team for STEMI Patients is Associated with Improved Late Clinical Outcomes. Acta Cardiol Sin 2016;32:428-438. (SCI)
  98. Yu HP, Jen HL, Yin WH*, Wei J. Circulating Adiponectin Levels Following Treatment Can Predict Late Clinical Outcomes in Chronic Heart Failure. Acta Cardiol Sin 2017;33:139-149. (SCI) (NSC 99-2320-B-350-002-MY3)
  99. Wang CC, Chang HY, Yin WH, Wu YW, Chu PH, Wu CC, Hsu CH,
    Wen MS, Voon WC, Lin WS, Huang JL, Chen SM, Yang NI, Chang HC, Chang KC, Sung SH, Shyu KG, Lin JL, Mar GY, Chan KC, Kuo JY, Wang JH, Chen ZC, Tseng WK, Cherng WJ. TSOC-HfrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management. Acta Cardiol Sin 2016;32:400-411. (SCI)
  100. Lin GM, Li YH, Yin WH, Wu YW, Chu PH, Wu CC, Hsu CH, Wen MS, Voon WC, Wang CC, Yeh SJ, Lin WS; Taiwan Society of Cardiology (TSOC) Heart Failure with Reduced Ejection Fraction (HFrEF) registry investigators and committee. The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients. Am J Cardiol 2016;118:1011-8. (SCI)
  101. Reyes EB, Ha JW, Firdaus I, Ghazi AM, Phrommintikul A, Sim D, Vu QN, Siu CW, Yin WH, Cowie MR. Heart failure across Asia: Same healthcare burden but differences in organization of care. Int J Cardiol 2016;223:163-167. (SCI)
  102. Yoon SH, Lefèvre T, Ahn JM, Perlman GY, Dvir D, Latib A, Barbanti M, Deuschl F, De Backer O, Blanke P, Modine T, Pache G, Neumann FJ, Ruile P, Arai T, Ohno Y, Kaneko H, Tay E, Schofer N, Holy EW, Luk NH, Yong G, Lu Q, Kong WK, Hon J, Kao HL, Lee M, Yin WH, Park DW, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Kim HS, Butter C, Khalique OK, Schaefer U, Nietlispach F, Kodali SK, Leon MB, Ye J, Chevalier B, Leipsic J, Delgado V, Bax JJ, Tamburino C, Colombo A, Søndergaard L, Webb JG, Park SJ. Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis. J Am Coll Cardiol 2016;68:1195-205. (SCI)
  103. Jen HL, Liu PL, Chen YH, Yin WH*, Chen JW, Lin SJ. Peroxisome Proliferator-Activated Receptor 𝛼 Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-𝜅B and Adiponectin. Mediators Inflamm 2016;2016:5609121. (SCI) (NSC 99-2320-B-350-002-MY3) (振陽計畫no. 98F117CY09)
  104. Mitomo S, Naganuma T, Fujino Y, Kawamoto H, Basavarajaiah S, Pitt M, Yin WH, Tresukosol D, Colombo A, Nakamura S. Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry. Circ Cardiovasc Interv 2017;10:e004265. (SCI)
  105. Jen HL, Yin WH*, Chen JW, Lin SJ. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin. J Atheroscler Thromb 2017;24:508-517. (SCI) (振陽計畫no. 98F117CY09)
  106. Chiang CE, Wu TJ, Ueng KC, Chao TF, Chang KC, Wang CC, Lin YJ, Yin WH, Kuo JY, Lin WS, Tsai CT, Liu YB, Lee KT, Lin LJ, Lin LY, Wang KL, Chen YJ, Chen MC, Cheng CC, Wen MS, Chen WJ, Chen JH, Lai WT, Chiou CW, Lin JL, Yeh SJ, Chen SA. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation. J Formos Med Assoc 2016;115:893-952. (SCI)
  107. Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Identification of new biosignatures for clinical outcomes in stable coronary artery disease – The study protocol and initial observations of a prospective follow-up study in Taiwan. BMC Cardiovasc Disord 2017;17:42. (SCI)
  108. Chang HY, Wang CC, Wu YW, Chu PH, Wu CC, Hsu CH,Wen MS, Voon WC, Lin WS, Huang JL, Chen SM, Yang NI, Chang HC, Chang KC, Sung SH, Shyu KG, Lin JL, Mar GY, Chan KC, Kuo JY, Wang JH, Chen ZC, Tseng WK, Cherng WJ, YinWH*. One-Year Outcomes of Acute Decompensated Systolic Heart Failure in Taiwan: Lessons from TSOC-HFrEF Registry. Acta Cardiol Sin 2017;33:127-138. (SCI)
  109. Chien SC, Chen CY, Leu HB, Su CH, Yin WH, Tseng WK, Wu YW, Lin TH, Chang KC, Wang JH, Wu CC, Yeh HI, Chen JW. Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease. Int J Cardiol 2017;241:1-5. (SCI)
  110. Liang FW, Lu TH, Wu HM, Lee JC, Yin WH*. Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications – a nationwide population-based study. BMC Cardiovasc Disord 2017;17:149. (SCI)
  111. Hsu CH, Tung HH, Clinciu DL, Chen LK, Yin WH, Iqbal U, Wang TJ. Physical activity: A primary health quality determinant among community-dwelling geriatric women in Taiwan. Int J Qual Health Care 2017;29:792-796. (SCI)
  112. Huang CL, Jen HL, Huang WP, Tsao TP, Young MS, Yin WH*. The Impact of Fractional Flow Reserve-Guided Coronary Revascularization in Patients with Coronary Stenoses of Intermediate Severity. Acta Cardiol Sin 2017;33:353-361. (SCI)
  113. Lin FJ, Tseng WK, Yin WH, Yeh HI, Chen JW, Wu CC. Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus. Sci Rep 2017;7:9179. (SCI)
  114. Huang CC, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Optimal achieved blood pressure for patients with stable coronary artery disease. Sci Rep 2017;7:10137. (SCI)
  115. Liang FW, Lee JC, Lu TH, Yin WH*. Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001-2013. Catheter Cardiovasc Interv 2017 Sep 30. doi: 10.1002/ccd.27343. [Epub ahead of print] (SCI)
  116. Chang HY, Wang CC, Wei J, Chang CY, Chuang YC, Huang CL, Chong E, Lin JL, Mar GY, Chan KC, Kuo JY, Wang JH, Chen ZC, Tseng WK, Cherng WJ, Yin WH*. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry. J Chin Med Assoc 2017;80:750-757. (SCI)
  117. Chen YL, Cheng CL, Huang JL, Yang NI, Chang HC, Chang KC, Sung SH, Shyu KG, Wang CC, Yin WH, Lin JL, Chen SM; TSOC-HFrEF Registry investigators and committee. Mortality prediction using CHADS2/CHA2DS2-VASc/R2CHADS2 scores in systolic heart failure patients with or without atrial fibrillation. Medicine 2017;96:e8338. (SCI)
  118. Yeh YT, Yin WH, Tseng WK, Lin FJ, Yeh HI, Chen JW, Wu YW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? ‒ Data from a multicenter registry cohort study in Taiwan. PLoS One 2017;12:e0186861. (SCI)
  119. Lu TH, Li ST, Liang FW, Lee JC, Yin WH*. When high-volume PCI operators in high-volume hospitals move to lower volume hospitals-Do they still maintain high volume and quality of outcomes? Catheter Cardiovasc Interv 2017 Oct 31. doi: 10.1002/ccd.27403. [Epub ahead of print] (SCI)
  120. Yoon SH, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, Yzeiraj E, Amat-Santos IJ, Tchetche D, Jung C, Fujita B, Mangieri A, Deutsch MA, Ubben T, Deuschl F, Kuwata S, De Biase C, Williams T, Dhoble A, Kim WK, Ferrari E, Barbanti M, Vollema EM, Miceli A, Giannini C, Attizzani GF, Kong WKF, Gutierrez-Ibanes E, Jimenez Diaz VA, Wijeysundera HC, Kaneko H, Chakravarty T, Makar M, Sievert H, Hengstenberg C, Prendergast BD, Vincent F, Abdel-Wahab M, Nombela-Franco L, Silaschi M, Tarantini G, Butter C, Ensminger SM, Hildick-Smith D, Petronio AS, Yin WH, De Marco F, Testa L, Van Mieghem NM, Whisenant BK, Kuck KH, Colombo A, Kar S, Moris C, Delgado V, Maisano F, Nietlispach F, Mack MJ, Schofer J, Schaefer U, Bax JJ, Frerker C, Latib A, Makkar RR. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. J Am Coll Cardiol 2017;70:2752-2763. (SCI)
  121. Lee YT, Yin WH*, Yu HP, Wei J. Use of Internal Endoconduit for Unfavorable Iliac Artery Anatomy in Patients Undergoing Transcatheter Aortic Valve Replacement – A Single Center Experience. Acta Cardiol Sin 2018;34:37-48. (SCI)
  122. Chang HY, Lo LW, Chen YR, Chou YH, Lin WL, Lin YJ, Yin WH, Feng AN, Chen SA. The autonomic neural mechanism of right ventricular outflow tract tachycardia. Auton Neurosci 2018;212:10-16. (SCI)
  123. Chiang CE, Lin SY, Lin TH, Wang TD, Yeh HI, Chen JF, Tsai CT, Hung YJ, Li YH, Liu PY, Chang KC, Wang KL, Chao TH, Shyu KG, Yang WS, Ueng KC, Chu PH, Yin WH, Wu YW, Cheng HM, Shin SJ, Huang CN, Chuang LM, Lin SJ, Yeh SJ, Sheu WH, Lin JL. 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases. J Chin Med Assoc 2018;81:189-222. (SCI)
  124. Zhang JJ, Gao XF, Han YL, Kan J, Tao L, Ge Z, Tresukosol D, Lu S, Ma LK, Li F, Yang S, Zhang J, Munawar M, Li L, Zhang RY, Zeng HS, Santoso T, Xie P, Jin ZN, Han L, Yin WH, Qian XS, Li QH, Hong L, Paiboon C, Wang Y, Liu LJ, Zhou L, Wu XM, Wen SY, Lu QH, Yuan JQ, Chen LL, Lavarra F, Rodríguez AE, Zhou LM, Ding SQ, Vichairuangthum K, Zhu YS, Yu MY, Chen C, Sheiban I, Xia Y, Tian YL, Shang ZL, Jiang Q, Zhen YH, Wang X, Ye F, Tian NL, Lin S, Liu ZZ, Chen SL. Treatment effects of systematic two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomised and multicentre DEFINITION II trial. BMJ Open 2018;8:e020019. (SCI)
  125. Chen KC, Yin WH, Wu CC, Chan SH, Wu YW, Yang Wang K, Chang KC, Hwang JJ, Voon WC, Hsieh IC, Chong JT, Lin WS, Hsu CN, Ueng KC, Hsia CP, Liu JC, Yeh JS, Mar GY, Shih JY, Kuo JY, Tsao HM, Tseng WK, Yang CH, Chang CC, Chiang CE, Lei MH, Lin JF, Shyu KG. In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome – Data from TSOC ACS-DM Registry. Acta Cardiol Sin 2018;34:211-223. (SCI)
  126. Ho LT, Lin FJ, Tseng WK, Yin WH, Wu YW, Li YH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study. J Formos Med Assoc 2018;117:814-824. (SCI)
  127. Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Cheng Chang K, Wang JH, Wu CC, Chen JW. Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease. J Formos Med Assoc 2018 Sep 19. pii: S0929-6646(16)30469-7. doi: 10.1016/j.jfma.2018.08.021. [Epub ahead of print] (SCI)
  128. Ho SK, Wu YW, Tseng WK, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Yeh HI, Wu CC, Chen JW. The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease. Sci Rep 2018;8:14410. (SCI)
  129. Wu JR, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention. Sci Rep 2019;9:3091. (SCI)
  130. Chang HY, Feng AN, Fong MC, Chong E, Yin WH*. Managements and outcomes of hospitalized heart failure patients with paroxysmal vs nonparoxysmal atrial fibrillation in Taiwan. J Chin Med Assoc 2019;82:356-62. (SCI)
  131. Jong CB, Li HY, Pan SL, Hsieh MY, Su FY, Chen KC, Yin WH, Chan SH, Wu YW, Wang KY, Chang KC, Hwang JJ, Wu CC. Relationship Between Body Mass Index, Antidiabetic Agents, and Midterm Mortality in Patients With Both Type 2 Diabetes Mellitus and Acute Coronary Syndrome. J Am Heart Assoc 2019;8:e011215. (SCI)
  132. Hsu CY, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Chou RH, Huang CY, Huang PH, Leu HB, Yin WH, Wu CC, Lin SJ, Chen JW. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease. Arterioscler Thromb Vasc Biol 2019;39:1240-52. (SCI)
  133. Chang HY, Feng AN, Fong MC, Hsueh CW, Lai WT, Huang KC, Chong E, Chen CN, Chang HC, Yin WH*. Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation. J Cardiol 2019;74:372-80. (SCI)
  134. Tzeng YH, Wei J, Tsao TP, Lee YT, Lee KC, Liou HR, Sung HJ, Huang KC, Hsiung MC, Yin WH*. Computed Tomography-Determined Muscle Quality Rather Than Muscle Quantity Is a Better Determinant of Prolonged Hospital Length of Stay in Patients Undergoing Transcatheter Aortic Valve Implantation. Acad Radiol 2019 May 31. pii: S1076-6332(19)30244-2. doi: 10.1016/j.acra.2019.05.007. [Epub ahead of print] (SCI)
  135. Akdogan RE, Srialluri S, Abdelsalam MGA, Hsiung MC, Nanda NC, Fadala H, Yin WH. Incremental value of right parasternal transthoracic echocardiographic examination over the left parasternal approach in assessing ascending aorta size: Additional benefit of three-dimensional echocardiography. Echocardiography 2019;36:1306-14. (SCI)
  136. Wang CC, Wu CK, Tsai ML, Lee CM, Huang WC, Chou HH, Huang JL, Chi NH, Yen HW, Tzeng BH, Chang WT, Chang HY, Wang CH, Lu YY, Tsai JP, Su CH, Cherng WJ, Yin WH, Tsai CT, Wu YW, Lin JL, Hwang JJ. 2019 Focused Update of the Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure. Acta Cardiol Sin 2019;35:244-83. (SCI)
  137. Huang KC, Yin WH, Lee YT, Tsao TP, Lee KC, Hsiung MC, Wei J. Quantification of Stent Creep by Three-Dimensional Transesophageal Echocardiography in Patients Undergoing Transcatheter Aortic Valve-in-Valve Implantation for Failed Bioprostheses. Acta Cardiol Sin 2019;35:380-6. (SCI)
  138. Chang HY, Chen KC, Fong MC, Feng AN, Fu HN, Huang KC, Chong E, Yin WH*. Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management. J Cardiol 2019 Sep 26. pii: S0914-5087(19)30264-3. doi: 10.1016/j.jjcc.2019.08.005. [Epub ahead of print] (SCI)
  139. Tzeng YH, Lee YT, Tsao TP, Lee KC, Huang KC, Hsiung MC, Wei J, Yin WH*. Performance and short-term outcomes of three different transcatheter aortic valve replacement devices in patients with aortic stenosis: A single-center experience. J Chin Med Assoc 2019;82:827-34. (SCI)
  140. Huang WP, Yin WH, Chen JS, Huang PH, Chen JW, Lin SJ. Fenofibrate Reverses Dysfunction of EPCs Caused by Chronic Heart Failure. J Cardiovasc Transl Res 2019 Nov 7. doi: 10.1007/s12265-019-09889-y. [Epub ahead of print] (SCI)
  141. Hung-Yu Chang, Yu-Wen Su, An-Ning Feng, Man-Cai Fong, Kuan-Chih Huang, Eric Chong, Kuan-Chun Chen and Wei-Hsian Yin:Prescription patterns of diabetes medications influencing clinical outcomes of heart failure patients with reduced ejection fraction.ESC Heart Failure 2020; 7: 604–615 (SCI)
  142. Chang HY, Yin WH, Hsiung MC, Young MS. A heart reversed triply: situs inversus totalis with congenitally corrected transposition of the great arteries in a middle-aged woman. Echocardiography. 2009; 26(5):617-21. (SCI)
  143. Hung-Yu Chang (MD), Kuan-Chun Chen (MD), Man-Cai Fong (MD),An-Ning Feng (MD), Hao-Neng Fu (MD), Kuan-Chih Huang (MD),Eric Chong (MD)e, Wei-Hsian Yin (MD, PhD):Recovery of left ventricular dysfunction after sacubitril/valsartan:predictors and management.Journal of Cardiology 75 (2020) 233–241(SCI)
  144. Chih-Chan Lien,Wei-Hsian Yin,De-Ming Yang,Luen-Kui Chena,Chien-Wei Chenh,Shui-Yu Liu,Ching-Fai Kwok,Low-Tone Ho,Chi-Chang Juan：Endothelin-1 induces lipolysis through activation of the GC/cGMP/Ca 2+/ERK/CaMKIII pathway in 3T3-L1 adipocytes .Biochim Biophys Acta Mol Cell Biol Lipids . 2022 Feb;1867(2):159071.
  145. Yung-Tsai Lee, Wei-Hsian Yin, Tien-Ping Tsao, Kuo-Chen Lee,Ming-Chon Hsiung, Yun-Hsuan Tzeng and Jeng Wei：The Presence of Calcified Raphe Is an Independent Predictor of Adverse Long-Term Clinical Outcomes in Patients With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.Front. Cardiovasc. Med., 13 April 2022
  146. Chia-Hui Tan, Yung-Tsai Lee, Yu Chen Kuo,Tien-Ping Tsao, Kuo-Chen Lee, Ming-Chon Hsiung,Jeng Wei, Kuan-Chia Lin and Wei-Hsian Yin：Clinical outcomes and cumulative healthcare costs of TAVR vs. SAVR in Asia.Front Cardiovasc Med 2022;9:973889.
  147. Wei-Hsian Yin, Yung-Tsai Lee, Tien-Ping Tsao, Kuo-Chen Lee, Ming-Chon Hsiung, Jeng Wei：Outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation with the use of newer- vs. early-generation devices.Ann Transl Med 2022;10(1):24

REVIEW ARTICLES:

  1. Chen YH, Huang PH, Lin FY, Chen WC, Chen YL, Yin WH, Man KM, Liu PL. Magnolol: A multifunctional compound isolated from the Chinese medicinal plant Magnolia officinalis. Eur J Integr Med 2011;3:e317-e324. (SCI)
  2. Yin WH, Chen JW, Lin SJ. Prognostic Value of Combining Echocardiography and Natriuretic Peptide Levels in Patients with Heart Failure. Curr Heart Fail Rep 2012;9:148-53.
  3. Liu JT, Chen YL, Chen WC, Chen HY, Lin YW, Wang SH, Man KM, Wan HM, Yin WH, Liu PL, Chen YH. Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol 2012;2012:871272. (SCI)
  4. Yin WH. Rotational atherectomy: an Update. J Geriatr Cardiol 2013;10:211-2. (SCI)
  5. Chen CY, Chuang SY, Fang CC, Huang LC, Hsieh IC, Pan WH, Yeh HI, Wu CC, Yin WH, Chen JW. Gender disparities in optimal lipid control among patients with coronary artery disease. J Atheroscler Thromb 2014;21(Suppl 1):S20-8. (SCI)
  6. Lee YT, Yin WH*, Yu HP, Wei J. Simultaneous Rota-stenting and Transcatheter Aortic Valve Implantation for Patients with Heavily Calcified Coronary Stenosis and Aortic Stenosis. J Chin Med Assoc 2016;79:512-516. (SCI)
  7. Yin WH*. ARNI: A New Paradigm for the Treatment of Heart Failure in Taiwan? Acta Cardiol Sin 2016;32:397-399. (SCI) (Editorial Comment)
  8. Lu TH, Li ST, Yin WH*. Graphical Representations of Mortality Data with Confidence Intervals. Circ Cardiovasc Qual Outcomes 2017;10:e002763. (SCI)
  9. Yin WH*. Transcatheter Aortic Valve Implantation in Taiwan: Still Evolving! Acta Cardiol Sin 2017;33:350-52. (SCI) (Editorial Comment)

CASE REPORT:

  1. Liou JY, Kong CW, Yin WH, et al. Pacemaker Twiddler’s syndrome: report of two cases. Acta Cardiol Sin 1992;8:240-4. (SCI)
  2. Huang CM, Yin WH, Jen HL, Young MS. Restrictive cardiomyopathy in a patient with primary (AL) cardiac amyloidosis: should heart transplantation be performed? – a case report and review. Acta Cardiol Sin 1998;14(2):77-81. (SCI)
  3. Liu BY, Jen HL, Huang CM, Yin WH, et al. Thyrotoxicosis complicated by coronary artery spasm and transient severe mitral regurgitation – Report of a rare case. Acta Cardiol Sin 2000;16:115-122. (SCI)
  4. Yin WH, Jen HL, Young MS. Spontaneous Reattachment of a Dislodged Atrial Lead. PACE 2001;24:912-913. (SCI)
  5. Wei JH, Yin WH*, Chiang MC, et al. Late hemopneumothorax resulting from subclavian venipuncture for transvenous permanent pacemaker implantation-report of two cases. Acta Cardiol Sin 2002;18:43-47. (SCI)
  6. Jen HL, Yin WH, Young MS. Thrombocytopenia following tirofiban therapy after coronary stenting-a case report. Taiwan Crit Care Med 2002;4:101-106.
  7. Yang YN, Yin WH, Young MS. Partial absence of the left pericardium-a case report. Acta Cardiol Sin 2002;18:83-87. (SCI)
  8. Jen HL, Tsai SH, Wang CJ, Yin WH, et al. Acute hyponatremia and hypokalemia associated with Indapamide. Acta Cardiol Sin 2002;18:206-10. (SCI)
  9. Yang YN, Yin WH*, Young MS. Safe right bundle branch block pattern during permanent right ventricular pacing. J Electrocardiol 2003;36(1):67-71. (SCI)
  10. Chiang MC, Yin WH*, Chuang YC, et al. Acute myocardial infarction complicated with right ventricular floating necrotic tissue and biventricular thrombi – a case report. Acta Cardiol Sin 2003;19:58-62. (SCI)
  11. Yin WH, Young MS, Lan GY, Chung MT, Wei J. Osteogenic sarcoma metastatic to the heart via infradiaphragmatic venous extension – a case report. Acta Cardiol Sin 2004;20:52-5. (SCI)
  12. Chiang MC, Yin WH*, Jen HL, Young MS. Implantation of a passive fixation dual chamber pacemaker in a patient with persistent left superior vena cava. J Chin Med Assoc 2004;67:37-40.
  13. Chen CC, Hsiung MC, Wei J, Chang WT, Yin WH, Young MS. Mitral annular subvalvular left ventricular aneurysm. Echocardiography 2005;22:434-7. (SCI)
  14. Chen CC, Hsiung MC, Chiang MC, Yeh PF, Chang WT, Yin WH, Young MS. Echocardiographic and electrocardiographic manifestations of heart metastasis from primary lung cancer. Am J Geriatr Cardiol 2006;15:322-5. (SCI)
  15. Yang YN, Chuang YC, Yin WH, Young MS. Catecholamine-induced cardiomyopathy secondary to pheochromocytoma mimicking fulminant acute myocarditis. Acta Cardiol Sin 2007;23:125-30. (SCI)
  16. Huang CL, Feng AN, Chuang YC, Lan GY, Hsiung MC, Lee JY, Yin WH*, Young MS. Malignant presentation of cardiac hemangioma: a rare cause of complete atrioventricular block. Circ-Cardiovasc Imag 2008;1:e1-e3. (SCI)
  17. Chang HY, Yin WH*, Hsiung MC, Young MS. A heart reversed triply: situs inversus totalis with congenitally corrected transposition of the great arteries in a middle-aged woman. Echocardiography 2009;26:617-21. (SCI)
  18. Ou CH, Chou YP, Hsiung MC, Wei J, Chang CY, Yin WH, Tsai SK. The utility of live three-dimensional echocardiography in the surgical treatment of bilateral coronary fistulas. Echocardiography 2009;26:859-61. (SCI)
  19. Hsieh CY, Feng AN, Yin WH, Young MS. Sudden cardiac death caused by an obstructive left atrial ball thrombus. Taiwan Crit. Care Med. 2009;10:313-17.
  20. Hsieh CY, Yin WH, Young MS, Wang JC. Severe spontaneous multiple coronary artery spasm during coronary angiography. J Intern Med Taiwan 2010;21:359-65.
  21. Chuang YC, Yin WH, Hsiung MC, Tsai SK, Lee KC, Huang HJ, Ou CH, Chang CY, Wei J, Chou YP. Successful Transcatheter Closure of a Residual Patent Ductus Arteriosus with Complex Anatomy after Surgical Ligation Using an Amplatzer Ductal Occluder Guided by Live Three-Dimensional Transesophageal Echocardiography. Echocardiography 2011;28:E101-3. (SCI)
  22. Chang HY, Yin WH*. Anomalous Right Coronary Artery Arising from Left Coronary Sinus in Two Brothers. Acta Cardiol Sin 2011;27:124-7. (SCI)
  23. Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS. Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman. Emerg Med Australas 2011;23:372-5. (SCI)
  24. Mishra J, Puri HP, Hsiung MC, Misra S, Khairnar P, Laxmi Gollamudi B, Patel A, Nanda NC, Yin WH, Wei J, Tsai SK, Sudhakar S. Incremental Value of Live/Real Time Three-Dimensional over Two-Dimensional Transesophageal Echocardiography in the Evaluation of Right Coronary Artery Fistula. Echocardiography 2011;28:805-8. (SCI)
  25. Khairnar P, Hsiung MC, Mishra S, Nanda NC, Daly DD Jr, Nayyar G, Patel A, Mishra J, Chuang YC, Tsai SK, Yin WH, Wei J. The ability of live three-dimensional transesophageal echocardiography to evaluate the attachment site of intracardiac tumors. Echocardiography 2011;28:1041-5. (SCI)
  26. Chen SY, Lee KC, Hsiung MC, Yin WH*. Live/Real Time Three-Dimensional Transesophageal Echocardiography in the Assessment of Aortic Root Patch Dehiscence. Echocardiography 2012;29:E233-6. (SCI)
  27. Wei J, Hsiung MC, Tsai SK, Yin WH, Ou CH, Donmez C, Bicer E, Daly DD Jr, Dumaswala B, Dumaswala K, McKay J, Nanda NC. Atrial septal occluder device embolization to an iliac artery: a case highlighting the utility of three-dimensional transesophageal echocardiography during percutaneous closure. Echocardiography 2012;29:1128-31. (SCI)
  28. Hsiung MC, Yin WH, Lee YT, Wei J. Delayed rupture of left ventricular apex after heart transplantation: diagnosis by two- and three-dimensional transthoracic echocardiography. Echocardiography 2013;30:E26-7. (SCI)
  29. Lin CP, Wang JH, Lee WL, Ku PM, Yin WH, Tsao TP, Chang CJ. Mechanism and management of burr entrapment: A nightmare of interventional cardiologists. J Geriatr Cardiol 2013;10:230-4. (SCI)
  30. Yin WH, Wei J, Tsai SK, Hsiung MC, Lee YT, Yu HP, Ou CH. Transcatheter Intervention for Complex Ascending Aortic Pseudoaneurysm After Cardiac Surgery. Circ J 2014;78:2215-8. (SCI) (病例分析)
  31. Chen ML, Chen MY, Yin WH, Wei J, Wang JH. Delayed Infective Endocarditis with Mycotic Aneurysm Rupture below the Mechanical Valved Conduit after the Bentall Procedure. Acta Cardiol Sin 2014;30:341-345. (SCI)
  32. Yu HP, Feng AN, Tsai SK, Hsiung MC, Yin WH*. Transcatheter Repair of Iatrogenic Aortic Perforation Complicating Transseptal Puncture for a Catheter Ablation of Atrial Arrhythmia. Acta Cardiol Sin 2014;30:490-492. (SCI)
  33. Lee YT, Yin WH*, Yu HP, Tsai SK, Wei J*. Transcatheter Aortic Valve Implantation in a Woman with Porcelain Aorta, Previous Sternotomy for Coronary Artery Bypass Grafting, and Critical Aortic Stenosis. Acta Cardiol Sin 2015;31:78-82. (SCI) (共同通訊作者)
  34. Wang YC, Feng AN, Yin WH, Young MS. A very rare abnormal course of the thoracic venous system: Long journey to the right ventricle. Heart Rhythm Case Reports 2015;1:366-368.
  35. Yu HP, Huang CH, Hou SM, Hsiung MC, Tsai SK, Yin WH*. Percutaneous transcatheter closure of mitral paravalvular leak via transarterial retrograde approach. J Geriatr Cardiol 2015;12:683-6. (SCI)
  36. Lee YT, Yin WH, Tsai SK, Hsiung MC, Wei J, Yu HP. Transcatheter Closure of Atrial Septal Defect with Attenuated Anterior Rim after Transcatheter Aortic Valve Implantation: Can It Be Carried out as a Single Procedure? Echocardiography 2016;33:320-2. (SCI)
  37. Serkan B, Hsiung MC, Nanda NC, Hardas S, Mohamed A, ElKaryoni A, Srialluri S, Barssoum K, Elsayed M, Wei J, Yin WH. Incremental value of live/real time three-dimensional transthoracic echocardiography over the two-dimensional technique in assessing carcinoid heart disease involving the aortic valve. Echocardiography 2016;33:1741-4. (SCI)
  38. Wang M, Chang TY, Yin WH, Yang YN. Right Ventricle Mimics Right Atrium at First Glance: A Rare Case of Congenital Right Sided Partial Pericardial Defect. Acta Cardiol Sin 2016;32:748-50. (SCI)
  39. Hsiao BY, Tsao TP, Yin WH*. Does fluorescein-induced anaphylactic shock trigger late drug-eluting stent thrombosis and cause lethal ST-elevation myocardial infarction? Resuscitation & Intensive Care Med 2017;2:22-26.
  40. Tsai SK, Hsiung MC, Wei J, Lee YT, Yu HP, Ou CH, Yin WH*. Transesophageal echocardiography for incremental value of Amplatezer cribriform septal occluder for percutaneous transcatheter closure of complex septal defects: Case series. J Chin Med Assoc 2017;80:333-40. (SCI)
  41. Arisha MJ, Hsiung MC, Ahmad A, Nanda NC, Elkaryoni A, Mohamed AH, Yin WH. Incremental benefit of three-dimensional transesophageal echocardiography in the assessment of left main coronary artery stent protrusion. Echocardiography 2017;34:915-918. (SCI)
  42. Elkaryoni A, Hsiung MC, Arisha MJ, Ahmad A, Nanda NC, Mohamed AH, Attia D, Sachdeva A, Singh L, Yin WH. Does three-dimensional transesophageal echocardiography provide incremental value in percutaneous closure of ascending aortic pseudoaneurysm? Echocardiography 2017;34:1057-1061. (SCI)

CO-INVESTIGATORS OF MAJOR CLINICAL TRIALS:

  1. Kim KS, Fan WH, Kim YD, Zhu W, Ngau YY, Tong P, Kim BS, Santos M, Lin WH, Buranakitjaroen P, Massaad R, Smith RD; Asia HEAALTH Study Investigators (…, Yin WH,…). Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy. Hypertens Res 2009;32:520-6. (SCI)
  2. Urban P, Abizaid A, Banning A, Bartorelli AL, Baux AC, Džavík V, Ellis S, Gao R, Holmes D, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Worthley S; e-SELECT Investigators (…, Yin WH,…). Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. J Am Coll Cardiol 2011;57:1445-54. (SCI)
  3. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators (…, Yin WH,…). Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med 2012;366:20-33. (SCI)
  4. Abizaid A, Costa JR Jr, Banning A, Bartorelli AL, Dzavik V, Ellis S, Gao R, Holmes DR Jr, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Orlick A, Spaulding C, Worthley S, Urban PM; e-SELECT Investigators (…, Yin WH,…). The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry. JACC-Cardiovasc Inte 2012;5:64-71. (SCI)
  5. Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P, Hokusai-VTE Investigators (…, Yin WH,…). Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013;369:1406-15. (SCI)
  6. Lin TH, Lai WT, Hsin HT, Li AH, Wang CL, Kuo CT, Hwang JJ, Chiang FT, Chang SC; ACS Full Spectrum Registry Investigators (…, Yin WH,…). Effects of clopidogrel on mortality, cardiovascular and bleeding outcomes in patients with chronic kidney disease – data from Taiwan acute coronary syndrome full spectrum registry. PLoS One 2013;8:e71917. (SCI)
  7. Lin TH, Hsin HT, Wang CL, Lai WT1, Li AH, Kuo CT, Hwang JJ, Chiang FT, Chang SC, Chang CJ; Taiwan ACS Full Spectrum Registry Investigators (…, Yin WH,…). Impact of impaired glomerular filtration rate and revascularization strategy on one-year cardiovascular events in acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry. BMC Nephrol 2014;15:66. (SCI)
  8. Chiang FT, Shyu KG, Wu CJ, Mar GY, Hou CJ, Li AH, Wen MS, Lai WT, Lin SJ, Kuo CT, Kuo C, Li YH, Hwang JJ; ACS Full Spectrum Registry Investigators (…, Yin WH,…). Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry. J Formos Med Assoc 2014;113:794-802. (SCI)
  9. O’Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators (…, Yin WH,…), Steen DL. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA 2014;312:1006-15.

CONFERENCE PAPER:

  1. Yin WH, Lin SL, Chen CH, et al. Assessment of aortic regurgitation by color doppler flow mapping. 1990; ROC Society of Cardiology 20th Annual Scientific Session. (Abstract).
  2. Yin WH, Liou JY, Chen CH, et al. Spontaneous echo contrast within right atrium: a sign of right-sided blood stasis? 1991; ROC Society of Cardiology 21st Annual Scientific Session. (Abstract).
  3. Pao YL, Yin WH, Chen CH, et al. Computer-assisted analysis of the exercise testing. 1991; ROC Society of Cardiology 21st Annual Scientific Session. (Abstract).
  4. Liou JY, Kong CW, Yin WH, et al. The clinical significance of right bundle branch block electrocardiographic pattern after transvenous permanent right ventricular pacemaker implantation. 1991, IXth World Symposium on Cardiac Pacing and Electrophysiology. (Abstract)
  5. Yin WH, Kong CW, Pao YL, et al. Effect of adjustment of the ST segment measurement point on exercise testing in the diagnosis of coronary artery disease. 1992; ROC Society of Cardiology 22nd Annual Scientific Session. (Abstract).
  6. Liou JY, Chen CH, Yin WH, et al. The preliminary experience with biplane transesophageal echocardiography. 1992; ROC Society of Cardiology 22nd Annual Scientific Session. (Abstract).
  7. Kong CW, Yin WH, Chan WL, et al. Physiological ST segment duration response to heart rate changes in normal adults. 1992; ROC Society of Cardiology 22nd Annual Scientific Session. (Abstract).
  8. Chen CH, Lin SL, Ho SJ, Yin WH, et al. Mitral regurgitation after double balloon or Inoue balloon mitral valvuloplasty: an echocardiographic study. 1992; ROC Society of Cardiology 22nd Annual Scientific Session. (Abstract).
  9. Lai ZY, Chen CH, Liou JY, Yin WH, et al. The utility of transesophageal echocardiography in detecting aortic valve disease. 1992; ROC Society of Cardiology 22nd Annual Scientific Session. (Abstract).
  10. Chang WH, Chen CH, Fang CH, Liou JY, Yin WH, et al. Effect of mitral regurgitation on pulmonary venous velocities: a transesophageal echocardiographic study. 1992; ROC Society of Cardiology 22nd Annual Scientific Session. (Abstract).
  11. Chen JW, Ting CT, Chan WL, Yin WH, et al. Coronary microvascular dysfunction in patients with idiopathic syncope and positive head-up tilting (vasodepressor syncope). 1994; ROC Society of Cardiology 24th Annual Scientific Session. (Abstract).
  12. Yin WH, Chen JW, Hsu TL, et al. Transesophageal echocardiographic determination of coronary flow reserve: a validation study. (Abstract) Acta Cardiol Sin 1996;12(Suppl):77.
  13. Yin WH, Huang CM, Jen HL, et al. Preoperative assessment of the best fitting electrode length in single lead VDD pacing by transthoracic echocardiography. (Abstract) PACE 1999; 22[pt.II]:828.
  14. Yin WH, Chiang MC, Huang CM, Jen HL, Young MS. Development of a new echocardiographic method for choosing the best fitting electrode length in single lead VDD pacing. (Abstract) Acta Cardiol Sin 1999;15(Suppl):59.
  15. Huang CM, Young MS, Liu BY, Jen HL, Wang JJ, Yang YN, Wei JH, Chiang MC, Yin WH, et al. Natural history and predictors of 1-year outcome in Chinese patients with severe heart failure for heart transplantation. (Abstract) Acta Cardiol Sin 2000;16(Suppl):4.
  16. Yin WH, Jen HL, Chiang MC, et al. Preoperative selection of the best fitting electrode length in single lead VDD pacing by transthoracic echocardiography. (Abstract) Acta Cardiol Sin 2001;17(Suppl):29.
  17. Wei JH, Yin WH, Huang CM, et al. Prevention of radiographic-contrast-agent induced reductions in renal function by acetylcysteine. (Abstract) Acta Cardiol Sin 2001;17(Suppl):107.
  18. Huang CM, Yang YN, Wei JH, Huang HS, Jen HL, Wang JJ, Chiang MC, Huang WB, Yin WH, et al. Transradial coronary intervention in Chinese patients: a single-center experience. (Abstract) Acta Cardiol Sin 2001;17(Suppl):115.
  19. Yin WH, Chen JW, Jen HL, et al. The prognostic value of soluble cellular adhesion molecules in patients with chronic congestive heart failure. (Abstract) Acta Cardiol Sin 2002;18(Suppl):30.
  20. Jen HL, Huang WP, Feng AN, Yin WH, et al. Soluble cellular adhesion molecules in patients with acute coronary syndrome. (Abstract) Acta Cardiol Sin 2002;18(Suppl):59.
  21. Yin WH, Chen JW, Young MS. The prognostic value of circulating soluble cell adhesion molecules in patient with chronic congestive heart failure. (Abstract) The Journal of heart failure 2002;7(1):72.
  22. Yin WH, Chen JW, Lin SJ, Young MS. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Advances in heart failure – proceedings of the 8th world congress on heart failure – mechanisms and management. 2002:311-314. (Abstract)
  23. Yin WH. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. (Abstract) Acta Cardiol Sin 2003;19(Suppl):107.
  24. Huang WP, Yin WH, Jen HL, Chiang MC, Feng AN, Young MS. C-reactive protein levels in patients with congestive heart failure. (Abstract) Acta Cardiol Sin 2003;19(Suppl):44.
  25. Chiang MC, Chen JW, Yin WH, Young MS, Lin SJ. The effect of L-arginine on endothelial dysfunction in Taiwanese patients with coronary heart disease. (Abstract) Acta Cardiol Sin 2003;19(Suppl):P10.
  26. Jen HL, Yin WH, Young MS. Comparison of lipanthyl and mevalotin on vascular reactivity and inflammation in patients with diabetes mellitus and coronary artery disease. (Abstract) Acta Cardiol Sin 2003;19(Suppl):P13.
  27. Wang JJ, Yin WH, Huang CM, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS, Wei J. Angiographic incidence of primary congenital anomalies of the coronary arteries: a coronary arteriographic study. (Abstract) Acta Cardiol Sin 2003;19(Suppl):P39.
  28. Yin WH, Chen JW, Young MS, Lin SJ. Oral L-arginine administration improves endothelial function in Chinese patients with coronary artery disease. 2003; 50th Anniversary Annual World Assembly of the American College of Angiology (Abstract).
  29. Yin WH, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS. Circulating tumor necrosis factor-alpha and soluble cell adhesion molecules may participate in the development of acute cardiogenic pulmonary edema. 2003; 11th Annual Scientific Session of the Society of Emergency & Critical Care Medicine, Taiwan, ROC. (Abstract).
  30. Yin WH, Chen JW, Young MS, Lin SJ. Fenofibrate reduces the adhesion of circulating monocytes from patients with severe congestive heart failure in tumor necrosis factor-alpha-stimulated human endothelial cells. (Abstract) Eur J Heart Fail 2004;3(Suppl):305.
  31. Yin WH. Inflammation in congestive heart failure. (Abstract) Acta Cardiol Sin 2004;20(Suppl II):97.
  32. Yin WH, Chen JW, Young MS, Lin SJ. Fenofibrate reduces tumor necrosis factor-alpha-induced human endothelial monocyte adhesion. (Abstract) Acta Cardiol Sin 2004;20(Suppl II):190.
  33. Jen HL, Yin WH, Chiang MC, Feng AN, Yang YN, Young MS. Ventricular overdrive pacing is not effective in treating sleep apnea syndrome. (Abstract) Acta Cardiol Sin 2004;20(Suppl II):191.
  34. Huang WP, Yin WH, Chang CY, Chuang YC, Young MS, Wei J. The prognostic value of circulating soluble cell adhesion molecules in cardiac allograft recipients. (Abstract) Acta Cardiol Sin 2004;20(Suppl II):207.
  35. Chiang MC, Yin WH, Jen HL, Lin YT, Young MS. Arterial compliance as a cardiovascular risk marker in asymptomatic Chinese individuals. (Abstract) Acta Cardiol Sin 2004;20(Suppl II):211.
  36. Yin WH, Jen HL, Lin YT, Chiang MC, Young MS. Brachial artery distensibility as a cardiovascular risk marker in asymptomatic individuals. (Abstract) Rev Clin Esp 2004;204(Supl 1):80.
  37. Yin WH. Cell adhesion molecules in patients with acute myocardial infarction complicated with cardiogenic pulmonary edema. Taiwan Society of Critical Care Medicine Annual Convention 2004. (Abstract)
  38. Yin WH. The prognostic value of soluble cellular adhesion molecules in patients with chronic congestive heart failure. Int J Cardiol 2004;97(Suppl 2):S11.
  39. Yin WH, Chen JW, Jen HL, Wang JJ, Huang WP, Feng AN, Chiang MC, Yang YN, Young MS, Lin SJ. Inhibitory effect of simvastatin, an HMG-COA reductase inhibitor, on endothelial monocyte adhesion in patients with severe congestive heart failure. Int J Cardiol 2004;97(Suppl 2):S59.
  40. Hsiung MC, Wei J, Chang CY, Chuang YC, Lee KC, Sue SH, Chou YP, Huang CM, Yin WH, Young MS, Tung TH. Long-term survival and prognostic implications of 2130 patients after coronary artery bypass grafting－seven-year follow up. Int J Cardiol 2004;97(Suppl 2):S37.
  41. Hsieh KS, Chang JK, Chien WY, Yin WH, Huang TC, Lin CC, Weng KP, Lee CL, Chien KJ, Chen FL. Transcatheter closure of patent ductus arteriosus with real time color three-dimentional echocardiographic monitoring. Int J Cardiol 2004;97(Suppl 2):S40.
  42. Chang JK, Chien WY, Yin WH, Chen FL, Hsio SH, Liu CP, Huang TC, Lin CC, Weng KP, Lee CL, Chien KJ, Hsieh KS. Transcatheter coil embolization of patent ductus arteriosus in adolescents and adults: usefulness and limitations. Int J Cardiol 2004;97(Suppl 2):S65.
  43. Chiang MC, Yin WH, Lin YT, Jen HL, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS. Usefulness of brachial artery distensibility in the prediction of coronary risk among asymptomatic individuals with and without metabolic syndrome. 2005; 1st International Congress on “Prediabetes” and the metabolic syndrome. (Abstract)
  44. Yin WH. Biochemical markers in cardiomyopathies. (Abstract) Acta Cardiol Sin 2005;21(Suppl I):25.
  45. Feng AN, Lin MW, Yin WH, Young MS. Association between G894T polymorphism in the endothelial nitric oxide synthase gene and circadian variation of blood pressure in patients with essential hypertension. 2005; 4th Asian-Pacific Congress of Hypertension. (Abstract)
  46. Yin WH, Liu PL, Young MS, Lin SJ, Kou YR. Induction of heme oxygenase-1 inhibits endothelial cell activation in patients with congestive heart failure: an in vitro study. (Abstract) Eur J Heart Fail 2005;4(Suppl):131.
  47. Yin WH, Liu PL, Young MS, Lin SJ, Kou YR. Induction of HO-1 suppresses endothelial angiotensin converting enzyme expression in patients with heart failure. (Abstract) 2005; 12th world congress on heart disease-new trends in research, diagnosis and treatment.
  48. Yin WH, Liu PL, Young MS, Lin SJ, Kou YR. Prophylactic effect of fenofibrate on endothelial activation and attenuation of HO-1 expression in patients with congestive heart failure. (Abstract) Acta Cardiol Sin 2005;21(Suppl III):26.
  49. Jen HL, Yin WH, Chiang MC, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS. Use of statins prior to percutaneous coronary intervention with drug-eluting stent reduces myonecrosis and improves clinical outcome. (Abstract) Acta Cardiol Sin 2005;21(Suppl III):179.
  50. Yang YN, Yin WH, Young MS, Lee JJ. An in vitro study on radiation dose and dose distribution pattern during endovascular brachytherapy. (Abstract) Acta Cardiol Sin 2005;21(Suppl III):179.
  51. Hsiung MC, Wei J, Chang CY, Chuang YC, Lee KC, Sue SH, Chou YP, Huang CM, Yin WH, Young MS, Tung TH. The effect on the different treatments of coronary artery disease with more than moderate ischemic mitral regurgitation: gender difference of long-term outcome and prognostic implications. (Abstract) Acta Cardiol Sin 2005;21(Suppl III):190.
  52. Wang JJ, Tung TH, Yin WH, Huang CM, Jen HL, Chiang MC, Huang WP, Feng AN, Yang YN, Young MS, Wei J. Influence of habitual alcohol consumption and lifestyle on high sensitivity c-reactive protein levels. (Abstract) Acta Cardiol Sin 2005;21(Suppl III):200.
  53. Jen HL, Yin WH, Chiang MC, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS. Use of statins prior to PCI with drug-eluting stenting reduces myonecrosis and improves clinical outcomes. (Abstract) 2005; Complex Catheter Therapeutics 2005.
  54. Yin WH. The role of biomarkers in heart failure. (Abstract) Acta Cardiol Sin 2006;22(Suppl I):67.
  55. Jen HL, Chiang MC, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS, Yin WH. Use of statins before percutaneous coronary intervention with the drug-eluting stent reduces periprocedural myonecrosis. Angioplasty Summit 2006 TCT Asia Pacific. (Abstract)
  56. Yin WH, Chen JW, Lin SJ, Young MS. Multimarker approach to risk stratification in chronic congestive heart failure. (Abstract) Eur J Heart Fail 2006;5(Suppl):690.
  57. Yin WH, Wang JJ, Jen HL, Chiang MC, Huang WP, Feng AN, Yang YN, Lin CC, Young MS. Low use of statins in patients with acute coronary syndrome. (Abstract) 2006; the annual scientific meeting of Taiwan Society of Lipids & Atherosclerosis 2006.
  58. Yin WH, Chen JW, Young MS, Lin SJ. Circulating adipokine levels in chronic heart failure. (Abstract) Acta Cardiol Sin 2006;22(Suppl II):19.
  59. Yin WH. How to handle case complications-coronary artery perforation. (Abstract) Acta Cardiol Sin 2006;22(Suppl II):115.
  60. Yin WH, Wang JJ, Jen HL, Chiang MC, Huang WP, Feng AN, Yang YN, Young MS. There remains substantial room to improve implementation of statin therapy to patients with acute coronary syndrome undergoing percutaneous coronary intervention. (Abstract) 2006; Complex Catheter Therapeutics 2006.
  61. Yin WH. Echocardiography for post-transplantation patients. (Abstract) 2006; The Society of Ultrasound in Medicine of the Republic of China 2006 Annual Convention.
  62. Yin WH, Chen JW, Young MS, Lin SJ. Independent prognostic value of elevated circulating adiponectin level in chronic heart failure. (Abstract) 2006; 28th World Congress of Internal Medicine.
  63. Yin WH, Chen JW, Lin SJ. Adhesion Molecules in Congestive Heart Failure. (Abstract) Int J Cardiol 2007;122(Suppl 1):S37-4.
  64. Cheng JJ, Chua SK, Hsieh IC, Yin WH, Young MS. Clinical outcomes of drug-eluting stent thrombosis in real-world experience: data from three medical centers in Taiwan. (Abstract) Int J Cardiol 2007;122(Suppl 1):S35-7.
  65. Yin WH, Wang JJ, Jen HL, Young MS. Underuse of statin therapy in patients undergoing emergency percutaneous coronary interventions. (Abstract) Am J Cardiol 2008;101(8B):31C.
  66. Yin WH. Treatments in Stable Multi-vessel CAD: Drug-eluting Stent. (Abstract) Acta Cardiol Sin 2008;June(Suppl I):28.
  67. Yin WH. Fenofibrate can inhibit heart failure serum-induced adhesion molecule expression in cultured human endothelial cells via heme oxygenase-1 regulation. (Abstract) 2008; 6th Congress of the Asian Pacific Society of Atherosclerosis and Vascular Disease & 10th Hong Kong Diabetes & Cardiovascular Risk Factors East Meets West Symposium.
  68. Yin WH. Resistant Hypertension. (Abstract) 2008; Annual Scientific Meeting of Taiwan Hypertension Society, 2008.
  69. Yin WH. The impact of introduction of novel techniques and devices on transradial coronary intervention for chronic total occlusion. (Abstract) 2009; Complex Cardiovascular Therapeutics 2009.
  70. Yin WH. Evolving trends of transradial percutaneous coronary intervention in the era of drug-eluting stents: comparison with a transfemoral approach. (Abstract) Am J Cardiol 2009;103(9A):61B.
  71. Yin WH. Transradial coronary intervention for chronic total occlusion. (Abstract) 2010; Asia PCR Singapore Live 2010.
  72. Yin WH. Transradial vs. Transfemoral Percutaneous Intervention for Bifurcation Lesions: Ten-Year Experience. (Abstract) 2010; China Interventional Therapeutics 2010.
  73. Yin WH, Jen HL, Young MS. Percutaneous Coronary Interventions for Cardiac Transplant Vasculopathy in Chinese Patients. (Abstract) Chinese Medical Journal (Beijing) 2010;123(Suppl 1):43.
  74. Yin WH, Jen HL, Huang WP, Young MS. Routine Transradial Primary Coronary Intervention for Acute ST-elevation Myocardial Infarction. (Abstract) Am J Cardiol 2010;105(9A):30B.
  75. Yin WH. Recent advance in management of heart failure: drugs. (Abstract) Acta Cardiol Sin 2010;26(Suppl I):206.
  76. Yin WH. ACS Treatment-Antithrombotic and Antiplatelet Therapy. (Abstract) 2010; Annual Scientific Meeting of Formosan Medical Association, 2010.
  77. Yin WH. Recognizing the link between CKD and CVD: assessment of proteinuria. (Abstract) Acta Cardiol Sin 2010;26(Suppl II):50.
  78. Yin WH. Real-world experience of GENOUS in Taiwan. (Abstract) Acta Cardiol Sin 2010;26(Suppl II):53.
  79. Tseng CK, Yin WH. Percutaneous Coronary Interventions for Cardiac Transplant Vasculopathy in Chinese Patients. (Abstract) 2011; Asia PCR Singapore Live 2011.
  80. Hwang SE, Yin WH, YEH MY. Cost-effectiveness analyses of drug-eluting versus bare-metal stents. (Abstract) 2011; Asia PCR Singapore Live 2011.
  81. Yin WH. Laser Angioplasty for Peripheral Vascular Disease. (Abstract) 2011; China Interventional Therapeutics 2011.
  82. Yin WH. Independent Prognostic Value of Elevated Adiponectin in Dilated Cardiomyopathy. (Abstract) Am J Cardiol 2011;107(8A):100A.
  83. Yin WH. The Role of Peroxidome Proliferator-activated Receptor-alpha in Heart Failure. (Abstract) Acta Cardiol Sin 2011;27(Suppl I):36.
  84. Chang HY, Yin WH, Wei J. The Predictors of Cardiac Allograft Vasculopathy and Its Clinical Outcomes from a Long-Term Follow up Cohort. (Abstract) Acta Cardiol Sin 2011;27(Suppl I):140.
  85. Huang YC, Yin WH. The New Scoring System (Syntax score + EuroScore) Improves the Predictive Ability in Treating Multivessel Coronary Disease. (Abstract) Acta Cardiol Sin 2011;27(Suppl I):141.
  86. Yin WH, Lin CC, Huang WP, Chen KC, Huang CL, Chang HY, Young MS. Use of the Magnetic Navigation System for Percutaneous Coronary Intervention: Initial Results of a Single Center. (Abstract) Acta Cardiol Sin 2011;27(Suppl I):143.
  87. Chen KC, Chen CD, Young MS, Yin WH. Clinical Outcome of Emergency Department In-hospital Tele-ECG Triage and Interventional Cardiologist Activation of the Infarct Team in Acute ST-Segment-Elevation Myocardial Infarction: Single Center Experience. (Abstract) Acta Cardiol Sin 2011;27(Suppl I):143.
  88. Yin WH. Cardiac Function and Heart Failure. (Abstract) Acta Cardiol Sin 2011;27(Suppl I):206.
  89. Huang YC, Hsiung MC, Yau LG, Yin WH, Lin CC. Isolated interventricular septal diverticulum presented as unstable angina-A case report. (Abstract)Acta Cardiol Sin 2011;27(Suppl I):237.
  90. Feng AN, Chang HY, Yin WH. The Long-term Follow-up of Anomalous Coronary Arteries Incidence and Clinical Outcomes in Patients Undergoing Coronary Angiography. (Abstract)Acta Cardiol Sin 2011;27(Suppl I):248.
  91. Chen SY, Yin WH. Right Ventricular Compression in Aortic Dissection. (Abstract)Acta Cardiol Sin 2011;27(Suppl I):250.
  92. Feng AN, Chang HY, Chiang MC, Yin WH. Catheter Ablation of Atrial Tachyarrhythmia in Patients with Prior Valvular Surgery. (Abstract)Acta Cardiol Sin 2011;27(Suppl I):259.
  93. Tseng CK, Chang HY, Yin WH. Predictors of Clinic Outcome of Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy. (Abstract)Acta Cardiol Sin 2011;27(Suppl I):266.
  94. Yu HP, Yin WH, Huang WP, Chang HY, Chen KC, Young MS. Randomized Study of Comparison between Conventional Coronary Angiography and Rotational One Concerning Contrast Utilization, Fluoroscopic Time and Procedure Time. (Abstract)Acta Cardiol Sin 2011;27(Suppl I):267.
  95. Chen SY, Yin WH, Chen KC. GRACE Scoring System is better than TIMI Scoring System in risk stratification of patients with Non-ST-segment elevation myocardial infarction. (Abstract)Acta Cardiol Sin 2011;27(Suppl I):268.
  96. Jen HL, Huang WP, Yin WH, Young MS. The Effect of Aliskiren on Endothelial Activation in Patients with Chronic Heart Failure. (Abstract)Acta Cardiol Sin 2011;27(Suppl I):269.
  97. Yin WH. Complications of rotational atherectomy. (Abstract) 2011; The 5th Oriental Congress of Cardiology (OCC 2011).
  98. Yin WH. Comparison among various DESs in treating left main bifurcation lesions. (Abstract) 2012; China Interventional Therapeutics 2012.
  99. Yin WH. How to retrieve a stuck rotablator burr? (Abstract) 2012; China Interventional Therapeutics 2012.
  100. Yin WH. Intervention strategy for restenosis of DES. (Abstract) 2012; The 14th South China International Congress of Cardiology 2012.
  101. Yin WH. Magnetic navigation for percutaneous coronary intervention: a single center experience. (Abstract) Am J Cardiol 2012;109(7S):41S.
  102. Yin WH. Second-generation vs. first-generation drug-eluting stent for unprotected left main stenting: is newer better? (Abstract) 2012; APSC Subspecialty Congress-Intervention and Imaging 2012 in
    conjunction with the 42nd TSOC Annual Meeting.
  103. Yin WH. Factor xa inhibition in secondary prevention of ACS. (Abstract) 2012; APSC Subspecialty Congress-Intervention and Imaging 2012 in conjunction with the 42nd TSOC Annual Meeting.
  104. Yin WH. Levosimendan in patients with acute heart failure. (Abstract) 2012; APSC Subspecialty Congress-Intervention and Imaging 2012 in conjunction with the 42nd TSOC Annual Meeting.
  105. Yin WH. Resveratrol may play a protective role in endothelin-1-induced cardiomyocyte hypertrophy. (Abstract) 2012; Heart Failure 2012 Congress.
  106. Yin WH. Debate: Is implantable loop recorder better than telemetry ECG in monitoring cardiac arrhythmia? – Con. (Abstract) 2012; The 5th Asia-Pacific Heart Rhythm Society Scientific Sessions In Conjunction with 8th Asia-Pacific Atrial Fibrillation Symposium.
  107. Yin WH. Lipid control and use of lipid-lowering drugs for secondary prevention of cardiovascular events in Taiwan: the Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (T-SPARCLE) Registry. (Abstract) Heart 2012;98(Suppl 2):E10-11.
  108. Yin WH. Transcatheter closure of ruptured sinus of valsalva aneurysm. (Abstract) 2013; China Interventional Therapeutics 2013.
  109. Yin WH. Antiplatelet strategies for post-PCI patients with atrial fibrillation comorbidity. (Abstract) 2013; China Interventional Therapeutics 2013.
  110. Yin WH. Challenging left main PCI case review 2: how did I solve the problem? (Abstract) 2013; China Interventional Therapeutics 2013.
  111. Yin WH. Trans-Apical Trans-Catheter Closure of Prosthetic Mitral Para-Valvular Leakage. (Abstract) 2013; 18th ANGIOPLASTY SUMMIT-TCTAP 2013.
  112. Yin WH. Successful TAVI in a Lady with Radiation-Induced Aortic Stenosis and Porcelain Aorta. (Abstract) 2013; 21st Annual Scientific Congress of Hong Kong College of Cardiology.
  113. Yin WH. Transradial vs. Transfemoral Approach for Rotablation. (Abstract) 2013; 21st Annual Scientific Congress of Hong Kong College of Cardiology.
  114. Yin WH. LM bifurcation intervention: to kiss or not to kiss. (Abstract) 2013; The 6th Left Main & Coronary Bifurcation Summit.
  115. Yin WH. Left main PCI in nonagenarian. (Abstract) 2013; The 6th Left Main & Coronary Bifurcation Summit.
  116. Yin WH. Conquer Challenges in Clinical Dilemma with CoCr Everolimus-Eluting Stent. (Abstract) 2014; China Interventional Therapeutics 2014.
  117. Yin WH. Transradial vs. Transfemoral Approach for Rotational Atherectomy. (Abstract) 2014; China Interventional Therapeutics 2014.
  118. Yin WH. Tele-ECG System to Improve D2B Time and Long-term Outcome in STEMI Patient. (Abstract) 2014; China Interventional Therapeutics 2014.
  119. Yin WH. When and how to use guideliner. (Abstract) 2014; 19th Cardiovascular Summit-TCTAP 2014.
  120. Yin WH. Transcatheter Aortic Valve Implantation. (Abstract) 2014; The 44th Annual Convention & Scientific Session of the Taiwan Society of Cardiology.
  121. Yin WH. PCI Guidelines in Cheng Hsin General Hospital. (Abstract) 2014; The 44th Annual Convention & Scientific Session of the Taiwan Society of Cardiology.
  122. Yin WH. Taiwan NHI Guidelines. (Abstract) 2014; The 44th Annual Convention & Scientific Session of the Taiwan Society of Cardiology.
  123. Yin WH. An old man needed 3 stent grafts to fix critical aortic stenosis and transsubclavian vascular access complication. (Abstract) 2014; EuroPCR 2014.
  124. Yin WH. Troubleshooting During TAVI Procedures. (Abstract) 2014; The 8th Oriental Congress of Cardiology (OCC 2014).
  125. Yin WH. Current Status of TAVI Procedure in Taiwan. (Abstract) 2014; 22nd Annual Scientific Congress Hong Kong College of Cardiology.
  126. Yin WH. What have we done in the hybrid room? (Abstract) 2014; 2014 China Congress of Structural Cardiology and National Cardiovascular Diseases Forum.
  127. Yin WH. Topics of Heart Failure: Guidelines and Practice. (Abstract) 2014; China Heart Congress 2014 (CHC 2014).
  128. Yin WH. The TAVI Program in Taiwan- Patient’s Choose. (Abstract) 2014; China Heart Congress 2014 (CHC 2014).
  129. Yin WH. CoreValve in Taiwan. (Abstract) 2014; Complex Cardiovascular Therapeutics 2014.
  130. Yin WH. Repair of transection of left subclavian artery: a TAVI vascular access complication. (Abstract) 2014; Complex Cardiovascular Therapeutics 2014.
  131. Yin WH. Stenting for distal unprotected left main coronary artery: to kiss or not to kiss? (Abstract) 2014; Complex Cardiovascular Therapeutics 2014.
  132. Yin WH. Long-term outcomes of patients with complex coronary artery disease and high SYNTAX score in contemporary practice. (Abstract) 2014; Complex Cardiovascular Therapeutics 2014.
  133. Yin WH. Paradigm shift in the management of type B aortic dissection. (Abstract) 2014; The 5th Cross-Straits Summit Forum & The 6th Xiamen Cardiovascular Interventional Symposium.
  134. Yin WH. My current idea about TAVI, what we have learned so far. (Abstract) 2014; The 5th Sendai / New Tokyo LIVE.
  135. Yin WH. Long term outcome after FFR vs. angio-guided PCI in patients with intermediate CAD. (Abstract) 2014; The 7th left main & coronary bifurcation summit.
  136. Yin WH. Case Presentation: Severe Aortic Valve Stenosis in Patient with Acute Pulmonary Edema, Low LVEF, and Shock. (Abstract) 2015; China Interventional Therapeutics in Partnership with TCT.
  137. Yin WH. Updates on the Emergence of TAVR in Taiwan. (Abstract) 2015; China Interventional Therapeutics in Partnership with TCT.
  138. Yin WH. BRS complex case reviews II. (Abstract) 2015; China Interventional Therapeutics in Partnership with TCT.
  139. Yin WH. Complications of TAVI: How to Deal with Them. (Abstract) 2015; Pediatric and Adult Interventional Cardiac Symposium, Asia-Pacific.
  140. Yin WH. Transcatheter repair of paravalvular leakage. (Abstract) 2015; The 17th South China International Congress of Cardiology.
  141. Yin WH. Transcatheter Closure of Mitral Paravalvular Leak via Retrograde Approach Without an Arteriovenous Loop. (Abstract) 2015; 20th Anniversary Cardiovascular Summit TCTAP 2015.
  142. Yin WH. Transcatheter closure of mitral prosthetic paravalvular leak via retrograde approach without an arteriovenous wire loop. (Abstract) 2015; EuroPCR 2015.
  143. Yin WH. How to deal with life-threatening complications during TAVI. (Abstract) 2015; 23rd Annual Scientific Congress Hong Kong College of Cardiology.
  144. Yin WH. The TAVI Strategy for one patient with combined AS and severe coronary stenosis. (Abstract) 2015; China Heart Congress 2015 (CHC 2015).
  145. Yin WH. The Good and Bad of BVS. (Abstract) 2015; The 9th Qianjiang International Cardiovascular Conference.
  146. Yin WH. Transcatheter Aortic Valve Replacement: what have we learned so far? (Abstract) 2015; The 9th Qianjiang International Cardiovascular Conference.
  147. Yin WH. TAVR Case Presentation-Transcatheter Valve-in-valve Implantation for failed Bioprostheses. (Abstract) 2015; The 9th Qianjiang International Cardiovascular Conference.
  148. Yin WH. Critical aortic stenosis with coronary artery disease: how to treat? (Abstract) 2015; The 17th Scientific Annual Congress of Chinese Society of Cardiology and The 9th Oriental Congress of Cardiology.
  149. Yin WH. Transcatheter Aortic Valve Replacement. (Abstract) 2015; World Association of Chinese Doctor Annual Conference 2015.
  150. Yin WH. Focus on New Guideline – TAVI as the New Strategy for High Risk Aortic Valvular Disease. (Abstract) 2015; The 26th Great Wall International Congress of Cardiology.
  151. Yin WH. My experience of BVS in Taiwan. (Abstract) 2015; The 6th Sendai / New Tokyo Live.
  152. Yin WH. Inflammation and biomarkers in congestive heart failure. (Abstract) 2015; 19th Annual scientific meeting of the institute of cardiovascular science and medicine.
  153. Yin WH. TAVI for “off-label” indications. (Abstract) 2015; The 6th Cross-Straits Cardiovascular Summit Forum & The 7th Xiamen Cardiovascular Interventional Symposium.
  154. Yin WH. Simultaneous rotational atherectomy and implantation of a self-expandable heart valve for patients with heavily calcified coronary stenosis and critical aortic stenosis. (Abstract) 2015; The 8th left main & coronary bifurcation summit.
  155. Yin WH. The good and bad of bioresorbable vascular scaffold. (Abstract) 2015; The 8th left main & coronary bifurcation summit.
  156. Yin WH. Transcatheter Implantation of a Self-expandable Heart Valve in Complex Aortic and Valvular Conditions after Cardiac and Aortic Root Surgery. (Abstract) 2016; Asia PCR Singapore Live.
  157. Yin WH. Transcatheter Aortic Valve Replacement in Taiwan. (Abstract) 2016; China Interventional Therapeutics in Partnership with TCT.
  158. Yin WH. When and how to do balloon aortic valvuloplasty in the context of TAVR. (Abstract) 2016; China Valve (Hangzhou).
  159. Yin WH. PVL performance, Asian anatomy. (Abstract) 2016; PCR Tokyo Valves 2016.
  160. Yin WH. Which patients could benefit the most from bioresorbable vascular scaffold implant? (Abstract) 2016; The 18th south china international congress of cardiology.
  161. Yin WH. TAVI complications. (Abstract) 2016; Cardiological Society of India – National Interventional Council.
  162. Yin WH. When and Why Would I Send Patients for CABG? – From A Interventionist’s Viewpoint. (Abstract) 2016; The 46th Annual Convention & Scientific Session of the Taiwan Society of Cardiology.
  163. Yin WH. TAVI at the Moment and in the Future. (Abstract) 2016; The 46th Annual Convention & Scientific Session of the Taiwan Society of Cardiology.
  164. Yin WH. TAVI at the Moment and in the Future. (Abstract) 2016; 24th Annual Scientific Congress of Hong Kong College of Cardiology 2016.
  165. Yin WH. Current status of TAVR in Taiwan. (Abstract) 2016; The 35th KSIC workshop.
  166. Yin WH. Remote monitor to shorten D2B time. (Abstract) 2016; Asia Primary Angioplasty Congress 2016.
  167. Yin WH. What should we know about TAVR? experiences from Taiwan. (Abstract) 2016; China Heart Congress 2016.
  168. Yin WH. From Taiwan 15 years evolution of coronary interventional therapy to see the influence of European and American guidelines. (Abstract) 2016; China Heart Congress 2016.
  169. Yin WH. Transapical Valve-in-Valve for Dysfunctional Mitral Bioprosthesis: Sapien XT vs. Lotus Valve. (Abstract) 2016; 5th AP VALVES 2016.
  170. Yin WH. Valve thrombosis: clinical significance and treatment. (Abstract) 2016; 5th AP VALVES 2016.
  171. Yin WH. Challenging situation 1: Valve-in-valve: mitral valve. (Abstract) 2016; 5th AP VALVES 2016.
  172. Yin WH. TAVR with a self-expandable CoreValve prosthesis for Pure Native Aortic Valve Regurgitation – a Challenging Case. (Abstract) 2016; The 64th Annual Scientific Session of the Japanese College of Cardiology.
  173. Yin WH. BVS clinical data and Taiwan experience. (Abstract) 2016; Annual Scientific Meeting of Macau Physician Society Advances in Medicine 2016.
  174. Yin WH. Cardiologist view of Syntax score. (Abstract) 2016; 2016 Taiwan Association of Thoracic & Cardiovascular Surgery.
  175. Yin WH. Catheter Intervention for Structure Heart Disease: Taiwan Situation. (Abatract) 2016; 7th Sendai New Tokyo Live Demonstration and 1st New Tokyo Academy of Cardiology.
  176. Yin WH. Discussion with Cardiac Surgeons – My recent idea of CABG. (Abatract) 2016; 7th Sendai New Tokyo Live Demonstration and 1st New Tokyo Academy of Cardiology.
  177. Yin WH. Strategy for patients with concomitant CAD and critical valvular aortic stenosis. (Abstract) 2016; The 9th left main & coronary bifurcation summit.
  178. Yin WH. Review of unmet needs in the treatment of heart failure. (Abstract) 2016; Scientific Congress & Annual Meeting, 2016. Taiwan Society of Internal Medicine.
  179. Yin WH. Current status of structural heart and coronary intervention: MitraClip. (Abstract) 2016; TSOC Winter Scientific Meeting.
  180. Yin WH. Sapien XT experience in Taiwan. (Abstract) 2017; Taiwan Transcatheter Therapeutics 2017.
  181. Yin WH. Myths of Heart Failure Management. (Abstract) 2017; TSOC 2017 Heart Failure Symposium-Unmet needs of heart failure management: linkage between Taiwan and the world.
  182. Yin WH. Transcatheter valve-in-valve implantation for dysfunctional aortic and mitral bioprostheses. (Abstract) 2017; Asia PCR Singapore Live.
  183. Yin WH. AMI case presentations – case 1. (Abstract) 2017; China Interventional Therapeutics in Partnership with TCT.
  184. Yin WH. How would I treat? (Abstract) 2017; China Interventional Therapeutics in Partnership with TCT.
  185. Yin WH. TAVR after bioprosthetic valve deterioration. (Abstract) 2017; China Interventional Therapeutics in Partnership with TCT.
  186. Yin WH. PCI and TAVR for concomitant valvular aortic stenosis and coronary artery disease. (Abstract) 2017; The 19th South China International Congress of Cardiology.
  187. Yin WH. How to choose correct THV and valve size. (Abstract) 2017; China Valve Hangzhou 2017.
  188. Yin WH. Valve in valve for degenerative bioprosthetic valve. (Abstract) 2017; 22nd Cardiovascular Summit TCTAP 2017.
  189. Yin WH. A case with coronary artery aneurysm and obstructive CAD. (Abstract) 2017; The 47th Annual Convention & Scientific Session of the Taiwan Society of Cardiology.
  190. Yin WH. Innovative TAVI devices from Asia-design features and clinical outcomes. (Abstract) 2017; EuroPCR 2017.
  191. Yin WH. BRS for complex coronary lesions: learning from cases and multicentre registry in Taiwan. (Abstract) 2017; EuroPCR 2017.
  192. Yin WH. Interpretations of NOBLE from physicians. (Abstract) 2017; The 11th Oriental Congress of Cardiology.
  193. Yin WH. PCI after TAVR-What should we concern? (Abstract) 2017; The 11th Oriental Congress of Cardiology.
  194. Yin WH. BRS for complex coronary lesions: experiences from Taiwan. (Abstract) 2017; KSIC Summer Conference 2017.
  195. Yin WH. PCI for CTO after TAVR with a Self-expandable Bioprosthesis. (Abstract) 2017; KSIC Summer Conference 2017.
  196. Yin WH. TAVR in Taiwan: Current Status and Prospects. (Abstract) 2017; China Heart Congress 2017.
  197. Yin WH. Aortic or Mitral Valve-in-Valve: Data and Devices. (Abstract) 2017; 6th AP Valves 2017.
  198. Yin WH. Transcatheter Mitral Valve-in-valve and Occluder Closure for Recurrent Leaks after Transcatheter Closure of Paravalvular Leak. (Abstract) 2017; 6th AP Valves 2017.
  199. Yin WH. Case Presentations-Very Late Scaffold Thrombosis of BVS. (Abstract) 2017; The 11th Qianjiang International Cardiovascular Conference.
  200. Yin WH. Optimal antithrombotic therapy after TAVR. (Abstract) 2017; ENCORE SEOUL 2017.
  201. Yin WH. Valve-in-valve: planning and technical tips. (Abstract) 2017; ENCORE SEOUL 2017.
  202. Yin WH. Transcatheter mitral valve therapy: Where do we stand? (Abstract) 2017; ENCORE SEOUL 2017.
  203. Yin WH. Vascular access issues in TAVR and structural heart procedures: how to avoid and how to manage? (Abstract) 2017; ENCORE SEOUL 2017.
  204. Yin WH. Dedicated bifurcation stents: where do we stand in 2017? (Abstract) 2017; ENCORE SEOUL 2017.
  205. Yin WH. Outcomes after Transradial versus Transfemoral Rota-stenting for heavily calcified Coronary Artery Disease. (Abstract) 2017; ENCORE SEOUL 2017.
  206. Yin WH. Outcomes after complete versus incomplete revascularization of patients with left main/multivessel coronary artery disease. (Abstract) 2017; ENCORE SEOUL 2017.
  207. Yin WH. Tips & Tricks in Valve-in-Valve TAVI. (Abstract) 2017; APCASH 2017.
  208. Yin WH. The next phase of TAVI evolution in Taiwan. (Abstract) 2017; APCASH 2017.
  209. Yin WH. TAVR for Pure Native Aortic Regurgitation- a Horrifying Ride. (Abstract) 2017; TCT 2017.
  210. Yin WH. TAVI Complications: avoiding with imaging – case presentation. (Abstract) 2017; 2017 PCR-CIT China Chengdu Valves.
  211. Yin WH. TAVI Complications: avoiding with imaging – case resolution and take-home message. (Abstract) 2017; 2017 PCR-CIT China Chengdu Valves.
  212. Yin WH. TAVI for failed surgical bioprosthesis – Live demo: case presentation. (Abstract) 2017; 2017 PCR-CIT China Chengdu Valves.
  213. Yin WH. PCI after TAVR with a self-expandable device. (Abstract) 2017; 2nd Complex PCI.
  214. Yin WH. PCI after TAVR: technical considerations. (Abstract) 2017; The 10th left main & coronary bifurcation summit.
  215. Yin WH. MitraClip (Percutaneous Mitral Valve Repair). (Abstract) 2017; Taiwan Society of Cardiology Winter Scientific Meeting.
  216. Yin WH. TAVI in Taiwan: What have we learned so far? (Abstract) 2018; Taiwan Transcatheter Therapeutics 2018.
  217. Yin WH. BPA experience in Taiwan. (Abstract) 2018; Asia PCR Singapore Live.
  218. Yin WH. A patient with right ventricular cardiogenic shock. (Abstract) 2018; Asia PCR Singapore Live.
  219. Yin WH. Valve durability after TAVI for younger patients. (Abstract) 2018; MIS-Korea 2018.
  220. Yin WH. TAVR in Taiwan: current status and challenges. (Abstract) 2018; China Interventional Therapeutics in Partnership with TCT 2018.
  221. Yin WH. Strategies for selection of vascular accesses and management of complications in TAVR. (Abstract) 2018; China Valve Hangzhou 2018.
  222. Yin WH. How to deal with complications during TAVI – how would I treat the case? (Abstract) 2018; PCR Tokyo Valves 2018.
  223. Yin WH. TAVI for the patients with small anatomy – key learnings. (Abstract) 2018; PCR Tokyo Valves 2018.
  224. Yin WH. PCI after TAVR: comparison between self-expandable and balloon-expandable Valves. (Abstract) 2018; 2018 South China International Congress of Cardiology.
  225. Yin WH. Indication of Balloon Dilated Valve in AS in Asia. (Abstract) 2018; The 12th Oriental Congress of Cardiology.
  226. Yin WH. Clinical outcomes after transcatheter valve-in-valve for failed surgical bioprosthesis. (Abstract) 2018; The 12th Oriental Congress of Cardiology.
  227. Yin WH. Is it the prime time to extend the indication of TAVR to younger patients? (Abstract) 2018; 26th Annual Scientific Congress Hong Kong College of Cardiology.
  228. Yin WH. The importance of complete revascularization-CABG vs. PCI. (Abstract) 2018; Tokyo Percutaneous Cardiovascular Intervention Conference 2018 (TOPIC 2018).
  229. Yin WH. Pushing the boundaries of TAVR. (Abstract) 2018; China Heart Congress 2018.
  230. Yin WH. Interventional treatment for patients with aortic insufficiency. (Abstract) 2018; China Heart Congress 2018.
  231. Yin WH. Performing coronary procedures after TAVR: tips and tricks. (Abstract) 2018; 14th Asian Interventional Cardiovascular Therapeutics.
  232. Yin WH. Case 6: How should I treat and how did I treat? A lady with radiation- induced aortic stenosis. (Abstract) 2018; The 12th Qianjiang International Cardiovascular Conference.
  233. Yin WH, Tsao TP, Wei J. Coronary procedures after TAVR with self-expandable valves vs. balloon-expandable valves. (Abstract) 2018; PCR London valves 2018.
  234. Yin WH. Taiwan Presents: Taiwan TAVR Registry. (Abstract) 2018; TCT 2018.
  235. Yin WH. Case 7: A Case of Pure Non-Calcific Aortic Insufficiency Treated with TAVR. (Abstract) 2018; TCT 2018.
  236. Yin WH. TAVR Case 1: An 85 year old lady with very early failure of transcatheter aortic valve, Discussion and Conclusion. (Abstract) 2018; APCASH 2018.
  237. Yin WH. Echo in Transcatheter Aortic Valve Replacement. (Abstract) 2018; 2018 Annual Convention of Taiwan Society of Ultrasound in Medicine.
  238. Yin WH. Why Angiotensin-Receptor/Neprilysin Inhibitor (ARNI) Decrease SCD Rather than ACEI/ARB in the Treatment of chronic HF? (Abstract) 2018; APHRS 2018.
  239. Yin WH. Do we really need BRS? (Abstract) 2018; BRS Symposium (TSCI).
  240. Yin WH. PCI in patients declined by surgeons (with case sharing). (Abstract) 2018; CHIP Symposium (TSCI).

中文著作:

  1. 殷偉賢, 林孝義, 鍾來如等. 一例再生不良貧血併血色素沉著病併發念珠菌關節炎之報告. 中華民國僂痲質學會年會, 1987. (摘要)
  2. 殷偉賢, 陳震寰, 徐粹烈等. 非風濕性心臟病併發左心房球形血栓. 臨床醫學 1990;25:239-41.
  3. 殷偉賢, 陳宗瀛. 不明源轉移癌引起之完全房室阻斷. 臨床醫學 1990;26:405-8.
  4. 殷偉賢, 陳震寰. 心臟之不明源轉移癌. 臨床醫學 1990;26:495-7.
  5. 殷偉賢, 林孝義, 顏慕庸等. 念珠菌關節炎: 兩例報告. 臺灣醫誌 1991;90:312-4.
  6. 殷偉賢, 江志桓. 硬膜外出血之心電圖變化. 臨床醫學 1991;27:240-2.
  7. 殷偉賢, 陳震寰. 二尖瓣氣球瓣膜擴張術後引發閉鎖不全之合併症. 臨床醫學 1991;28:314-6.
  8. 殷偉賢, 陳肇文, 江志桓. 心房副收縮. 臨床醫學 1991;28:395-7.
  9. 殷偉賢, 陳震寰. 創傷引起的平流型三尖瓣閉鎖不全血流. 臨床醫學 1992;29:246-9.
  10. 殷偉賢, 陳雲亮. 不明原因暈厥. 臨床醫學 1992;29:229-39.
  11. 殷偉賢, 劉哲仰, 江志桓. 以Vario 功能測定放置人工心節律器後之刺激閾. 臨床醫學 1992;29:463-6.
  12. 殷偉賢, 劉哲仰, 陳震寰. 右肺動脈及右心房血栓併發肺動脈高壓. 臨床醫學 1992;30:147-50.
  13. 殷偉賢, 陳震寰. 血液培養陰性之感染性心內膜炎. 臨床醫學 1992;30:289-90.
  14. 殷偉賢, 陳肇文, 任勗龍, 黃文彬, 馮安寧, 楊茂勳. 血清細胞吸附分子與末期心臟衰竭病患預後之研究. 台灣內科醫學會年會, 2001. (摘要)
  15. 殷偉賢, 陳肇文, 任勗龍, 江孟橙, 黃文彬, 馮安寧, 楊茂勳, 林幸榮. Simvastatin可有效減少重度心衰竭病患血液單核球與血管內皮細胞間黏附之現象. 台灣內科醫學會年會, 2003. (摘要)
  16. 蔡敬民, 殷偉賢, 鄭秀卿, 陳珮蓉, 林于鈴. L-Arginine對人體血脂濃度影響之初步探討. 中華民國營養學會雜誌 2004;29:176-83.
  17. 殷偉賢. 動脈硬化及其併發症 – 發炎反應扮演之角色. 中華民國重症醫學雜誌 2005;7:32-39.
  18. 殷偉賢, 馮安寧, 任勗龍, 江孟橙, 黃文彬, 楊永年, 楊茂勳. 以多重生物指標評估擴大性心肌病變患者之預後. 台灣內科醫學會年會, 2005. (摘要)
  19. 殷偉賢. 國家膽固醇教育計畫-成人治療專家小組治療指南的最新進展. 首屆海峽兩岸冠心病現代診療策略高峰論壇會, 2006. (摘要)
  20. 殷偉賢. 動脈硬化與發炎反應. 心肺血管病論壇 2007;4:15-18.
  21. 殷偉賢. 炎症在動脈粥樣硬化及其併發症中的作用. 第二屆海峽兩岸冠心病現代診治策略高峰論壇暨首屆長城國際心血管病學在線大會, 2007. (摘要)
  22. 熊仲川, 殷偉賢. 頑固型高血壓. 臺灣醫界 2007;50:177-180.
  23. 林淑霞, 劉榮宏, 殷偉賢, 陳冠群, 葉明陽, 蔡勝國, 陳俐君. 民眾對遠距健康照護服務之認知與需求調查研究－以心臟病、高血壓及糖尿病為範疇. 台灣公共衛生雜誌 2009;28:552-64.
  24. 殷偉賢, 李永在, 魏崢. 經導管主動脈瓣膜植入術：進展與現狀. 中國心血管雜誌 2014;19:338-40.
  25. 殷偉賢. 心臟病康復治療. 第五屆全國老年心血管疾病學術研討會, 2015. (摘要)
  26. 殷偉賢. 兩岸對話—旋磨轉速經驗探討. 海峽兩岸醫藥衛生交流協會心血管專業委員會第六屆年會, 2015. (摘要)
  27. 殷偉賢. 兩岸對話—旋磨操作手法技巧的解讀. 海峽兩岸醫藥衛生交流協會心血管專業委員會第六屆年會, 2015. (摘要)
  28. 殷偉賢. Fabry病的心臟病症. 海峽兩岸醫藥衛生交流協會心血管專業委員會第六屆年會, 2015. (摘要)
  29. 殷偉賢. 冠脈介入質控論壇—臺灣經驗. 海峽兩岸醫藥衛生交流協會心血管專業委員會第六屆年會, 2015. (摘要)
  30. 殷偉賢. 臺灣心臟康復進展. 2016第三屆廈門國際心臟康復論壇, 2016. (摘要)
  31. 殷偉賢. TAVI與MitraClip技術及進展. 第六屆全國老年心血管疾病學術研討會, 2016. (摘要)
  32. 殷偉賢. Future Perspectives of TAVR. 海峽兩岸醫藥衛生交流協會心血管專業委員會第七屆年會, 2016. (摘要)
  33. 殷偉賢. 經導管瓣中瓣植入術處理退變生物瓣膜. 海峽兩岸醫藥衛生交流協會心血管專業委員會第七屆年會, 2016. (摘要)
  34. 殷偉賢. TAVR入路選擇策略及併發症處理. 第十一屆錢江國際心血管病會議, 2017. (摘要)
  35. 殷偉賢. TAVI以及AVR的選擇. 第十二屆老年冠心病的診斷和治療國家級繼續教育學習班, 2017. (摘要)
  36. 殷偉賢. 經導管置換主動脈瓣膜植入術. 2017 TSCI秋季會醫事人員繼續教育課程, 2017. (摘要)
  37. 殷偉賢. 冠狀動脈旋轉研磨術-手術過程及技術人員注意事項. 2017 TSCI秋季會醫事人員ROTA訓練課程, 2017. (摘要)
  38. 殷偉賢. 急重症病人常見瓣膜疾病的診斷與處置. 中華民國急救加護醫學會第十八屆第二次會員大會暨學術研討會, 2017. (摘要)
  39. 殷偉賢. 經導管治療老年人瓣膜疾病. 第二屆海峽兩岸醫藥衛生交流協會老年醫學專業委員會年會, 2017. (摘要)
  40. 殷偉賢. 心衰全球治療現狀. 第二屆海峽兩岸醫藥衛生交流協會老年醫學專業委員會年會, 2017. (摘要)
  41. 殷偉賢. 台灣經導管MitraClip治療二尖瓣閉鎖不全的現狀及展望. 臺灣醫學會第110屆總會, 2017. (摘要)
  42. 殷偉賢. TAVR與SAVR的選擇. 海峽兩岸醫藥衛生交流協會心血管專業委員會第八屆年會, 2017. (摘要)
  43. 殷偉賢. 球囊擴張瓣膜的應用. 2018血管疾病多學科協作論壇, 2018. (摘要)
  44. 殷偉賢. TAVI不同併發症的預防與處理. 2018中華醫學會胸心血管外科青年醫師論壇, 2018. (摘要)
  45. 殷偉賢. 台灣心衰治療現況的省思與改善策略. 2018深圳心力衰竭國際發展論壇, 2018. (摘要)
  46. 殷偉賢. 股動脈入路TAVR評估及手術策略制定. 第十二屆錢江國際心血管病會議, 2018. (摘要)
  47. 殷偉賢. 中低危AS病人接受TAVR是否合宜? 第三屆海峽兩岸醫藥衛生交流協會老年醫學專業委員會年會暨第四屆海峽兩岸老年醫學論壇及重慶市2018年老年醫學學術年會, 2018. (摘要)
  48. 殷偉賢. 球囊擴張式瓣膜操作要點及技巧. 第二屆中國結構性心臟病週暨第二屆中國國際結構性心臟病學會議, 2018. (摘要)
  49. 殷偉賢. TAVR手術應否使用於低危及年輕病人? 海峽兩岸醫藥衛生交流協會心血管專業委員會第九屆年會, 2018. (摘要)
© 2023 Dr. Wei's Medical Heart Center. All rights reserved.